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INTRODUCTION  
Hemodialysis improves the quality of life in patients of end stage renal 
diseases. Hemodialysis (HD) is a type of machine with an artificial filter  
which removes wastes from the blood stream and regulates the body fluid 
mechanism and chemical balances. Vascular access acts as bridge between the 
patient and machine circuit hence it is called the Achillis heal of 
Hemodialysis [1,2]. 
In modern medicine, the use of temporary intravascular catheters for 
vascular access and hemodynamic monitoring has become a central part in 
patients undergoing hemodialysis. Central venous catheters (CVC) have 
significant benefits in many clinical situations but the major consequence of  
CVC is colonization of the catheter by either bacteria or fungi, which can lead 
to catheter related infection (CRI) and serious catheter related blood stream 
infection (CRBSI) which remain a major cause of nosocomial infections 
leading to significant patient morbidity, mortality and hospital costs [1,2,3,4] 
The frequency of hemodialysis is a risk factor for infection. 
Patients with renal impairment are at high risk of developing infection 
due to high uremic state, low immunity, severe clinical deterioration and need  
vascular access for Renal Replacement Therapy (RRT). [5] The risk of 
developing bacteremia varies with the site of CVC insertion, type of device 
and duration of CVC in situ.[6] 
CRBSI have increased in incidence during the past few decades. More 
than three fourth of the nosocomial bacteremias occurring in case clusters are 
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primary bacteremias and the case fatality rate of CRBSI has been estimated 
about 10-20% and more than 90% of CRBSI are associated with CVC[7,8].  
An estimated 248000 Blood Stream Infection (BSI) occur in United 
State Hospital each year[9]. More than 25000 patient develop device related 
bacteremias in US each year[7].  
The United States Centers for Disease Control (CDC) National 
nosocomial infection survey indicates that 82% of all episodes of nosocomial 
bacteremias occurring the survey hospitals and presence of CVC is the single 
biggest risk factor for BSI among HD patients[1,10]. 
 In early 1970’s HD was used all most exclusively for Acute Renal 
Failure(ARF). The vascular access devices particularly Internal Jugular Vein 
(IJV), femoral vein and subclavian vein are major source of infection, causing 
local and systemic infection like local cellulitis, abscess formation, septic 
thrombophlebitis, endocarditis and septicemia in the HD patients[11,12] 
HD patients are at a higher risk of developing fungal infections by 
pathogenic and opportunistic fungi due to the defective immune system[13]. In 
an immunosuppressed individual parasitic infection can cause profuse 
diarrhea, anorexia, malabsorption syndrome and weight loss. Accumulation of 
non excreted metabolites  by  kidney and  chronic renal insufficiency leads to 
uremia and induces a state of immunosuppression that results in higher 
frequency of aquring bactieral, fungal and parasitic infection through CVC, 
contact with nursing staff, equipment, material on surface and from hands [14].  
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CDC’s health care infection control practices advisory committee 
CDC/HIPAC guidelines for prevention of IVC related infection 2011 gives 
the guidance for prevention of Central Line Associated Blood Stream 
Infection (CLABSI)[15]. 
All these infections are reversible and in view of the signif icant 
morbidity and mortality among patients with CVC, early diagnosis,  
management and prevention of such infection is mandatory.  
This study was undertaken to determine the incidence of bacterial, 
fungal and parasitic infection in patient on hamodialysis with Central Venous 
Catheter, to analyze the associated risk factors and to perform antibacterial 
and antifungal susceptibility pattern. This study was done in the Institute of 
Microbiology in association with Department of Nephrology, Madras Medical 
College, Rajiv Gandhi Government General Hospital, Chennai. 
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REVIEW OF LITERATURE  
HISTORY OF DIALYSIS: 
1913  The term artificial kidney was coined by ABEL, ROWNTUE, 
TURNER at JOHNS HOPKINS in BALTIMORE. They devised 
a kidney using celloidin tubing for membranes and used crushed 
leach heads (Hirudin) for anticoagulation. The kidney worked 
inefficiently and the experimental animals died of 
hypersensitivity to hirudin. 
1923  N1CHIOLES in Germany used peritoneal membrane from an ox 
to make artificial kidney. 
1943  WILLEM KOLFF designed the rotating drum artificial kidney. 
It was used successfully in Holland, to treat patients with 
kidney failure. KOLFF published his design in 1946 
1947  KOLFF compared the effectiveness of peritoneal and intestinal 
lavage to hemodialysis and found hemodialysis superior for 
urea removal. 
1947  VONGARRETTS in COPENHAGEN made a hand wound coil 
kidney and used it successfully in humans.  
1953  TESCHAN and colleagues used artificial kidneys to treat battle 
injuries with acute renal failure in Korean hospitals. The 
survival of patients with battle injuries and acute renal failure 
was improved. 
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1956  KOLFF developed a disposable coil dialyzer. 
1957  KIIL developed the flat plate paralleled flow dialyzer.  
1959  SCRIBNER started the first two patients on chronic dialysis 
using the KIIL dialyzer. 
1964  Home dialysis was started by CURTIS and SCRIBNER . 
1965  The subcutaneous arterioverous fistula was developed by 
BRESCIA and CIMINO. 
1969  First used subclavian catheters by ERBENEL 
1974  Large surface area dialyzers became available that allowed a 
decrease in dialysis time. 
1979  ULDALL introduced Modified single needle dialysis cannula.  
1980  Automated peritoneal dialysis and Continuous ambulatory 
peritoneal dialysis widely accepted for chronic maintenance 
dialysis. 
1983  GRABE used inner surface of the cannula for semiquantitative roll 
plate culture of steel stiletto inserted in the lumen and drawn back 
and forth.  
1984               BOZETTI was used nonquantitative culture of catheter blood.  
1985  COOPER  performed Direct Grams staining of the catheter segment 
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1990  CERCENADO used semiquantitative catheter tip for colony count 
1992  CAPDEVILA introduced paired and unpaired quantitative blood 
culture methods. READ et al and GUTIERREZ et al used 
quantitative culture of catheter segment  
1993  KHARDORI  introduced culture of catheter segment embedded 
into agar.  
1993  RUSHFORTH  used catheter blood for Acridine Orange 
staining of monolayered leucocytes from pellet examining with 
UV microscope   
2001  Infectious disease society of America (IDSA) published a 
Clinical practice Guidelines on management of Intravascular 
catheter related infection.  
2008  Europian Renal Best Practice (ERBP) gives Guidelines for the 
exclusive management of hemodialysis.  
2009 Infectious Diseases Socity of America (IDSA) published an 
update of Clinical Practice Guidelines for the Diagnosis and 
Management of Intravascular catheter related infection. 
2011  CDC’s Healthcare Infection Control Practices Advisory 
Committee (CDC/HIPAC) released Guidelines for the 
prevention of Intravascular Catheter related Infection    
Acute hemodialysis access is through Internal Jugular, Subclavian and 
Femoral vein catheterization, using double lumen catheters.  
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End stage renal disease is a complete failure of ultra filtering capacity 
of kidneys which is a complication of many diseases as a result of the 
accumulation of metabolic byproducts, loss of controlling functions of 
kidneys on electrolytes, disturbance of several of the endocrine functions of 
kidney and ultimately leading to death[16]. The definite solution of the end 
stage renal disease is transplantation but not all the patients are suitable for 
transplant. Therefore the alternative is dialysis procedure which is based on 
circulating blood on one side of the semi permeable membrane against 
dialysis solutions on the other. Thereby they constantly remove the 
accumulated metabolic degradation products from the blood stream [17].  
INCIDENCE OF HEMODIALYSIS ASSOCIATED INFECTION 
In practice, one of the most frequent and serious complications of 
using CVC devices has been the development of infections. 400,000 episodes 
of vascular catheter related blood stream infections occurs in USA every 
year[16]. Infectious complications associated with the use of these devices 
range from 2.7% to 21%. More than 3/4 of the nosocomial bacteremia 
occurring in  case clusters are primary bacteremia and more than 75% of these 
are device related[7]. CRBSI is reported to be 2.5 – 5.5 cases per patient year.  
Canadian Nosocomial Infection Surveillance Program found that the risk of 
bacteremia is higher in cuffed or uncuffed CVC than Arterio Venous 
Fistula(AVF).[6,23]  Enhanced susceptibility secondary to the alterations in the 
immune response induced by uremic state play a major role in determining the 
type, incidence and outcome of infectious complications[18] 
8 
 
 
 Thoburu et al, and Ratnaja et al noted that septic thrombophlebitis in 
patients with central venous catheters may account for 20 % of hospital 
acquired septicemias.[6,19,20] Bacteremia during hemodialysis has been 
reported with an incidence of 0.15 episode per patients dialysis year[21,22].The 
mean incidence of CRBSI for ‘temporary –untunnelled’ catheters was 
reported as 5.0 episodes/1000 catheter days and 3.5/1000 catheter days for 
permenant – tunneled cuffed catheters[23]. CRBSI has been reported about 
15% in Mumbai , India.[2] 
HEMODIALYSIS  MODALITIES:[24,25] 
a. HEMODIALYSIS: 
1. Conventional  
2. Sequential Ultrafiltration / Clearance 
3. Ultrafiltration - Central Venovenous, Central Arteriovenous 
b. HEMOFILTRATION: 
1. Slow continuous ultrafiltration 
2. Continuous Arteriovenous Hemofiltration 
3. Continuous Arterio venous Hemodialysis  
4. Continuous Arteriovenous Hemodiafitration 
5. Continuous Venovenous Hemofiltration 
6. Continuous Venovenous Hemodialysis 
7. Continuous Venovenous Hemodiafiltration 
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INDICATIONS OF HEMODIALYSIS:[24,25,26] 
A.      ACUTE DIALYSIS: 
1. Uremic Syndrome 
2. Hyperkalemia 
3. Acidosis 
4. Fluid Overload 
5. Acute Renal Failure 
6. Organo Phosphorus Poisoning  
7. Acute Pulmonary embolism   
8. Cerebro Vascular Accident  
9. Congestive cardiac failure.  
B. CHRONIC DIALYSIS: 
Chronic Renal Failure 
End stage Renal disease  
C. OTHER INDICATIONS: 
1. Cirrhosis of Liver 
2. Guillian Barre Syndrome 
3. Hypokalemic Periodic Paralysis  
4.  Chronic Corpulmonale  
5. Pericardial effusion  
6. Myxoedoma coma  
7. Status Epilepticus 
8. Acute Myocardial infarction  
9. Cardiogenic Shock 
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10. Drug Interactions 
11. Hypercalcemia 
12. Hypothermia 
13. Hyperuricemia 
14. Metabolic Alkalosis 
ACCESS FOR HEMODIALYSIS: [27]  
Site from where the blood was taken out from the body and then 
returned to the blood stream is called Access. The various access modalities 
are Fistula, Graft and Catheter. 
Central venous catheter: Short term if the catheter was in place for less 
than 7days, Long term if it was more than 7 days  
1. PERCUTANEOUS VENOUS CATHETERS: 
a. Femoral Vein  
b. Subclavian Vein 
c. Internal Jugular Vein 
2. EXTERNAL ARTERIO VENOUS SHUNT: 
Radial Artery-Cephalic Vein 
3. ARTERIOVENOUS FISTULA: 
A. ENDOGENOUS: 
Radial Artery-Cephalic Vein 
Ulnar Artery-Brachiocephalic Vein 
Brachial Artery- Brachiocephalic Vein 
Femoral Artery-Saphenous vein 
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           B. PROSTHETIC: 
Dacron 
Polyurethane 
Polyethylene 
Polytetrafluroethylene 
TYPES OF VASCULAR ACCESS 
Acute Chronic 
External Arteriovenous Fistula Native Arteriovenous Fistula 
Double Lumen Catheter Synthetic Arteriovenous Fistula  
COMPLICATION OF HEMODIALYSIS: [6,25] 
Acute Chronic 
Pyrogenic Reaction Inadequate Clearance 
Hypotension Beta 2 Microglobulin Amyloidosis  
Anaphylaxis Aluminium Intoxication 
Arythmias Accelerated Atherosclerosis 
Bleeding Hypertrophic Cardiopathy 
Hypoxemia Infective endocarditis  
Cramps Septic Arthritis  
Hemolysis Septic Embolism  
Dialysis Disequilibrium Syndrome Osteomyelitis  
The development of infections in hemodialysis with the devices depend 
on the organism and dose, structure of the device material, fibrin, fibronectin 
and platelet deposits on the device and route of infection. 73% of  bacteremia 
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are due to access site infection.[28] The surface of all devices contains 
microscopic irregularities which may trap fibrin,  platelets and bacteria. 
Central Venous Catheter Related Infections are considered under two 
headings: They are 
LOCAL CATHETER INFECTIONS: 
a. EXIT OR INSERTION SITE INFECTION:[29] It is considered major 
portal of entry of microbial access leading to catheter related 
sepsis. Micro organisms grow proximally along the outside of the 
catheter, enter circulation via intravascular portion of catheter and 
cause sepsis. Presence of edema, erythema, thrombophlebitis or 
exudate formation around insertion site are the signs of infection.  
b. TUNNEL INFECTION: Spreading cellulitis around subcutaneous 
tract of long term tunelled catheter is termed as  tunnel infection[7] 
c.  CATHETER COLONIZATION: In the absence of clinical signs of 
infection at the exit site, < 15 CFU on quantitative culture or < 15 
CFU on semi quantitative culture of catheter segment is termed as 
catheter colonization. 
SYSTEMIC CATHETER RELATED SEPTICEMIA: 
It may be of two types, 
a. PROBABLE CATHETER RELATED SEPSIS OR PRIMARY SEPTICEMIA: 
Blood Stream infection caused by organisms from the skin of patients 
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with vascular catheters who have manifestation of sepsis and no 
apparent source of septicemia except the catheter. [29,30] 
b. DEFINITE CATHETER RELATED SEPTICEMIA: First degree septicemia 
for which there is clinical or positive quantitative culture implicating 
catheter as the source of sepsis.  
Criteria for systemic catheter related septicemia 
1. Pus at the insertion site: Isolation of the same organism from pus and 
blood stream. 
2. Clinical sepsis which is refractory to antibiotics but which resolves after 
removal of catheter. 
3. Positive quantitative catheter culture with the isolation of same organism 
from the catheter and blood stream. 
Differential quantitative blood culture > 10 fold increase in colony 
count of organisms isolated from the blood drawn through central catheters 
verses that simultaneously drawn from the peripheral venous blood [29] 
EPIDEMIOLOGY 
RISK FACTORS FOR INTRAVASCULAR CATHETER INFECTIONS: 
I.  HOST RELATED FACTORS:[6,7,26,] 
1. Elderly Patients  
2. Anaemia  
3. Hypoprotenemia 
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4. Diabetes Mellitus 
5. Recent hospitalization  
6. Recent surgery 
7. History of previous dialysis  
8. Peripheral atherosclerosis  
9. Personal hygeine  
10. Nasal carriage of Staphylococcus aureus  
11. Alteration on cutaneous flora 
12. Granulocytopenia 
13. Immunosuppresive therapy 
14. Loss of skin integrity eg: burns, psoriasis 
15. Severity of the underlying illness 
16. Presence of distant infection 
17. High cumulative dose of intravenous iron.  
18. Array of diagnostic and theraputic modalities. 
II. ENVIRONMENTAL RISK FACTORS: 
1. Type of catheter- plastic , steel 
2. Location of catheter- central, peripheral, femoral subclavian 
3. Duration of placement of catheter 
4. Type of procedure - emergency, elective 
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5. Skill of the venipuncturist 
6. Contaminated skin antiseptics 
7. Moisture around the dressing 
8. Tight or occlusive dressing 
9. Improper aseptic techniques 
10. Occurrence of clot at the tip of fibrin sleeve, insertion length.  
11. Maintenance of hygiene by the Health care provider - hand 
washing 
III. ADDITIONAL RISK FACTORS: 
1. Catheter composition /construction / flexibility / stiffness 
2. Microbial adherence properties - Hematogenous seeding of 
catheter 
3. Biofilm formation  
ETIOLOGICAL AGENTS 
SPECTRUM OF CATHETER RELATED BLOOD STREAM 
INFECTION [7,12,14,31,35-43,46] 
BACTERIAL 
Staphylococcus aureus           - Acinetobacter species 
Staphylococcus epidermidis  - Enterobacter species 
Corynebacterium jeikeium  - Klebsiella species 
Bacillus species    - Citrobacter species 
Pseudomonas aeruginosa  - Micrococcus species 
Stenotrophomonas maltophilia  - Enterococcus Species  
Aeromonas species   - Escherichia coli  
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Serratia marcescens - Polymicrobial 
ATYPICAL MYCOBACTERIA: 
Mycobacterium fortuitum 
Mycobacteriurn chelonae 
FUNGAL: 
Candida albicans 
Candida parapsilosis 
Candida tropicalis  
Malassezia furfur 
Rhodotorula species 
Fusarium species 
Trichosporon species 
PARASITIC:  
Blastocystis hominis 
Cryptosporidium parvum 
Isospora belli 
Endolimax nana 
Entamoeba coli 
Entamoeba hartmanni 
Dientamoeba fragilis  
ROUTES OF TRANSMISSION[31]: 
1. Intraluminal spread-contaminated entry port, contaminated fluid  
2. Extraluminal spread-hospital staff or patients micro flora, improper 
aseptic technique  
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3. Hematogenous spread 
4. Other routes - furniture, bed clothes, intensive care unit, contaminated 
medical device, antibiotic resistance, suppurative thrombophlebitis 
PATHOGENESIS 
The balance of forces between two competing life forms, the human 
host and the infecting microbe is popularly known as ‘EQUATION OF 
INFECTION’[7] Indwelling devices heavily bias the infection equation in 
favour of the parasite and enable non pathogenic bacteria to opportunistically 
infect foreign body. They cause chronic inflammation which cripples the 
ability of host to opsonize and phagocytose bacteria. [7,32]. 
There are three interactions in the pathogenesis of intravascular 
infections such as: 
a. Effect that the host has upon the medical device 
b. Effect that the medical device has upon the pathogen 
c. Effect that the pathogen has on the medical device[7] The striking 
feature of indwelling medical device is the diversity in function, 
design, construction and the location of these appliances.  
INTERACTION BETWEEN DEVICE AND HOST:[7] 
The magnitude of tissue response is influenced by the chemical 
composition, shape and mechanical stability of the implanted object e.g. very 
few plastics are chemically inert. The warm, wet and highly oxygenated 
environment of living tissue results in chronic inflammation which produces 
universal inflammatory reaction by the host. 
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INTERACTION BETWEEN DEVICE AND MICROBE[23]: 
        Intravascular catheters become rapidly coated with serum constituents  
that facilitate the attachment organisms  to foreign material. The microbial 
surface components recognize adhesive matrix molecules.  
Adherence of microorganism to the catheter surface occurs with the help o f  
(1) Microbial factors such as fibrous glycocalyx  
(2) Host factors such as fibronectin, fibrinogen, and laminin   
(3) Physical character of catheter surface.  
(4) Surface character of adherent bacteria 
(5) Intrinsic phenotypic change of adherent bacteria.  
MICRO ORGANISM ON CATHETER SURFACE TAKE TWO FORMS: 
[23,33,34] 
Intrinsic phenotypic changes trigger the expression of several enzymes 
that catalyze the production of exopolysaccaride which in tu rn form biofilm. 
Biofilm producing bacteria are resistant to glycopeptide antibiotics and also 
resistant to the host defenses against such as phagocytes and antibodies. 
Bacteria in biofilm are metabolically active. Microbial colonization and 
biofilm formation on the catheter surface occurs within 24 hours of insertion . 
a. Sessile adherent forms are those in which organisms are buried in the 
biofilm layer. They are retrieved by disruptive methods like 
VORTEXING. 
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b. Planktonic free floating forms in which the organisms disseminate over 
the catheter surface. They are retrieved by semiquantitative culture by 
ROLLPLATE METHOD. 
a. Skin Insertion Site: :[26,29,52] 
It is the common source of colonization and infection of vascular 
catheters occurring in < 10 days duration. Microbes migrate from the skin 
insertion site along the external surface and colonize distal intravascular tip 
of the catheter leading to blood stream infection. This was studied by Maki 
and diagnosed by Semiquantitative culture by  roll plate method.  
b. Hub Contamination:[23,29] 
It is more common in catheter which is in place for > 30 days duration. 
Organisms are introduced into the hub from hands of the medical personnel. 
They migrate along the internal surface of catheter leading to luminal 
colonization and blood stream infection. This was studied by Sitges et al and 
diagnosed by Intraluminal quantitative culture.  
Centers for Disease control (CDC) definition for central venous 
catheter – related blood stream infections[4]. 
Catheter exit – site infection 
A positive semi-quantitative cultures of the drainage material in the 
presence of redness, crusting and exudates at the catheter exit site.  
Catheter colonization 
In the absence of clinical signs of infection at the catheter exit site, <10CFU 
(colony forming units) on quantitative culture (vortex method) or <15 CFU on semi 
quantitative cultures (roll-plate technique)  
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Catheter – related blood stream infection 
The isolation of the same organism from a quantitative culture of the 
distal segment of the catheter and from the blood of a patient with clinical 
symptoms of sepsis in the absence of any other noticeable source of infection.  
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ORGANISMS CAUSING CATHETER RELATED BLOOD 
STREAM INFECTION ENTER THE BLOOD STREAM BY 
FOLLOWING METHODS 
 
 
 
Hemodialysis catheter – related infection 
Intraluminal Extraluminal 
Catheter handling with 
contaminated hands 
Bacterial migration from skin 
Contaminated Catheter 
hub 
Contaminated catheter 
exit site 
Intraluminal colonization 
of the catheter segment 
Extraluminal colonization 
of the catheter segment 
Multiplication of micro 
organism in the biofilm 
Further forward migration 
of microorganisms  
Catheter tip 
CRBSI 
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CLINICAL FEATURES OF CATHETER  INFECTION:[7] 
a. EXIT SITE INFECTION: Local warmth, Erythema. Tenderness, 
Purulent drainage, elevated temperature > 38 F. Exudate formation 
around 2 cms of the insertion site.  
b. TUNNEL INFECTION: Resemble exit infection. Tenderness and 
erythema which extend up to chest along subcutaneous tract at 
proximal end of the catheter. 
c. SEPTIC THROMBOPHLEBITIS: They reflect bacterial invasion and 
subsequent thrombosis of the vein. This is always bacteremic. Local 
signs of venous insufficiency such as edema of upper extremity are 
present. 
d. BACTEREMIA: This occurs in the absence of localizing signs or 
symptoms and common in immuno compromised and neutropenic 
individuals. They may present with fever of unknown origin and 
leucocytosis within 2 days of catheterization. 
IMMUNITY [23,46] 
Renal failure patients are prone to suffer from impaired immune 
defence mechanisms. Cell mediated immunity is altered by the presence of 
uremia, nutritional abnormalities and inflammation induced by HD filters that 
cause oxidative stress, apoptosis and produce T cell depletion. MHC class II 
analogue protein expressed by Staphylococcus aureus may attenuate the host 
cell mediated immunity by T cell proliferative response to Gram positive 
bacterial infections. The degree of impairment is related to the duration of 
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uremic state, lymphopenia and decreased lymphocytic response to antigenic 
stimulation. 
ANTIMICROBIAL RESISTANCE IN HEMODIOALYSIS 
In an emergence of antimicrobial resistance, a susceptible bacteria 
undergoes mutation and become a new resistant bacteria. Methicillin resistant 
Staphylococcus aureus (MRSA) are increasingly reported due to frequent 
hospitalization and antibiotic exposure. ESRD patients are especially 
vulnerable to infections with MRSA. 13% of MRSA infection has been 
reported from United States between 2004-2006 and the mortality for CRBSI 
about 35%. MRSA accounts for more than 26.7% cases in India.[56] Beta 
lactamase producing organisms (ESBL) were reported about 6.3% in India 
 INDICATIONS FOR HEMODIALYSIS CATHETER REMOVAL[23] 
Persistence of fever and positive blood culture while being on appropriate 
antibiotics for 36-48 hours.  
Recurrence of fever and bacteremia despite adequate dosage and duration of 
systemic antibiotic administration 
Exit site infections extending to catheter tunnel with severe sepsis 
CRBSI associated with hypotension or signs of cerebral hypoperfusion. 
Septic thrombosis of great veins as determined by a Doppler flow study.  
Infective endocarditis and systemic septic embolisation.  
OTHER ASSOCIATED INFECTIONS[47] 
Wound infection: Pus or redness at the wound not related to the vascular access 
Pneumonia: A new infiltrate or pneumia seen on chest radiograph 
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Urinary tract infection: Urine culture with >100,000 organism/ml with no more 
than two species isolated 
DISINFECTION STRATEGIES [23,54]  
Sterile technique and Hand hygiene: 
Good hand hygiene before insertion of catheter, proper aseptic 
technique, full barrier precaution during insertion of catheter will reduce the 
incidence of catheter related infection 
Cutaneous asepsis: 
Povidone iodine, chlorhexidine, tincture iodine or 70% alcohol are 
used to clean the surface. 
Catheter dressing:  
 Sterile, transparant, semipermeable dressings are used to cover the 
catheter. Antimicrobial / Antiseptic impregnated catheters : External surfaces 
of catheters are incorporated with Chorhexidine silver sulphadiazine  
LABORATORY DIAGNOSIS 
Standard blood culture methodology is the main stay of laboratory 
diagnosis. For the establishment of bacteremia, cultures should be drawn from 
distant site and not from the access device. Cultures drawn through the access 
site may help to document dialysis, may help in deciding whether to remove 
the catheter. The clinical appearance of the access site is important. 
Erythema, induration, edema and exudate confirm the presence of infection.  
Blood should be drawn in an aseptic manner with adequate volume and at an 
appropriate time before the usage of antibiotics.  
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A. CATHETER IN SITU: 
ERBP recommends Catheter sparing strategies recently to avoid 
unnecessary and wasteful removal of catheters.  
1. PAIRED QUANTITATIVE BLOOD CULTURE [48 – 51, 55] 
Simultaneous blood sample from the catheter and peripheral site are 
taken. A ratio of catheter and peripheral blood of 4:1 is considered 
significant. It has several advantages for the following reasons such that it has 
an ability to detect the organism within the lumen of the catheter, to evaluate 
relative number of organisms from different segments of the catheter.  
2. CATHETER SITE COLONIZATION [47,53] 
Yield of single or predominant pathogen of culture of skin swab taken 
at the insertion site. Skin is the most common source for short term catheter 
colonization and infections. 
B. CATHETER TIP PROCESSING 
GRAM STAINING OF CATHETER TIP  [8] 
COOPER HOPKINS found Gram Stain to be highly diagnostic but 
reporting needs at least fifteen minutes of microscopic scanning of catheter 
surface. 
DIRECT ACRIDINE ORANGE STAINING  [8] 
 RUSHFORTH and ZUFFERY et al used direct acridine orange 
staining and reported high sensitivity and specificity. Disadvantage are labor 
intensive, high cost and low positive predictive value.  
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SEMIQUANTITATIVE ROLLPLATE METHOD  [27,33,34] 
This method was established by Maki et al. It retrieves organism from 
the external surface of the catheter. Roll  plate of distal segment of the 
catheter and quantitative colony count indicates external surface colonization. 
It is significant if > 15 CFU detected.  
VORTEXING  [26,33,34] 
It indicate internal and external surface colonization. The procedure 
involves vortexing of the catheter tip followed by quantitative culture on  5% 
Sheep Blood Agar.   Michael  Kelly et al has described that a colony count of 
>100 CFU/ml is significant. 
BROTH CULTURE OF CATHETER TIP [1] 
 Catheter segment is immersed in trypticase soy broth, incubated at 37°C 
aerobically and examined daily for upto 72 Hours for turbidity.  
MANAGEMENT [23,52,55] 
It depends on the following principles:  
1. Extent of infection whether local or systemic. 
2. Micro organism causing infection 
3. Underlying condition of the catheterized host 
4. Intravenous treatment with appropriate antibiotics should be initiated on 
clinical grounds even without microbiological proof.  
5. Treatment with antibiotics should be continued for prolonged period.  
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6. If an abscess is present at access site, it should be drained immediately.  
7. If clinical improvement is not evident within 2 to 3 days, catheter should be 
removed. 
EXIT SITE INFECTION 
Treat with topical agents like povidone iodine, mupirocin. Sterile 
dressing and local care along with antibiotics without catheter removal will 
reduce the number of epispodes of bacteremia . 
TUNNEL INFECTION: 
More serious and requires catheter removal and appropriate antibiotics  
CATHETER RELATED BACTEREMIA[23] 
a. Staphylococcus epidermidis : Vancomycin - 7 days  
b. Staphylococcus aureus  : Semisynthetic pencillin - 2 weeks 
c. Gram Negative Bacilli : Aminoglycosides - 1 week 
d. Candida Species : Flucanozole - 14 days 
IDSA recommendation of antibiotic dosing for patients who are 
undergoing hemodialysis : 
Vancomycin 20mg/kg loading dose infused during last one hour of 
dialysis,500mg during the last 30 minutes of dialysis. 
Ceftazidaime 1g IV after each hemodialysis. 
Cefazolin 20 mg/kg after each hemodialysis 
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Candida infection 
Caspofungin 70mg IV loading dose followed by 50mg IV daily.  
Fluconazone 200mg orally daily. 
PREVENTION 
Following principles are useful in preventing infection: [52,55]  
1) Hemodialysis unit is ‘a restricted” site. Personnel and visitors should 
change and wear operating room type clothing and shoe covers.  
2) All access site puncture should be performed with meticulous sterile 
technique. Disinfection of site with 3% Iodine followed by 70% Ethyl 
alcohol is preferred. 
3) Regular cleaning schedule of dialysis unit with appropriate disinfectant 
should be established. 
4) Dialysis supply system should be operated at near sterile condition.  
5) Education of dialysis staff about design, operation, maintenance and 
potential hazards of Hemodialysis Equipment.  
6) Establishment of experienced infusion therapy team to insert and 
maintain catheters. 
7) Use of maximum sterile barriers. 
8) Use of Tunneling and Ionic Silver Cuffs which act as antimicrobial 
deterrent and a physical barrier to migration of bacteria.  
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9) Flushing of tunelled catheters with Heparin and Intraluminal antibiotic 
Locks. 
10) Antiseptic Hubs. 
11) Antimicrobial Coating of Catheters.  
12) Maximal sterile barrier precautions, asepsis and catheter dressing  
13) Proper selection of site for catheter placement  
14) Nasal decolonization of bacterial flora  
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AIMS & OBJECTIVES 
1. To isolate and identify the  bacteria and fungi from Central Venous 
Catheter related blood stream infections in patients undergoing 
hemodialysis 
2. To screen the patients for other bacterial, fungal and parasitic 
infections  
3. To study the risk factor associated with Central venous catheter related 
blood stream infection  
4. To study the antibiotic and antifungal susceptibility pattern of the 
isolated bacterial and fungal organisms.  
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MATERIALS AND METHODS 
In the Rajiv Gandhi Government General Hospital, Chennai, Hemodialysis 
was started in the year 1969, using Lucas Hemodialysis machine. Since then, 
hemodialysis facilities have improved. Now there are seven hemodialysis 
machines in the Hemodialysis unit of Department of Nephrology.  
PLACE OF STUDY: 
This cross sectional study was conducted in the Institute of Microbiology,  
in association with Department of Nephrology, Madras Medical College and 
Rajiv Gandhi Government General Hospital, Chennai. 
Study period and design 
This cross sectional study was done for period of one year from 
September 2011 to October 2012. 
Ethical consideration 
Approval was obtained from the institutional ethical committee before 
the commencement of the study. Informed consent was obtained from the study 
population. All patients satisfying the inclusion criteria were documented. 
Patients were interviewed by structured questionnaire.  
Study population 
150 adult inpatients with acute and chronic renal failure who undergo 
hemodialysis through central venous catheter, suspected having infection 
based on the clinical symptoms and signs were taken for the study.  
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CASE DEFINITION [4,34,52,53,56,57] 
Catheter Colonization 
The yield of > 15 CFU from a catheter, by means of semiquantitative 
culture or a yield of > 102 from a catheter, by means of quantitative culture in the 
absence of signs of infection is considered indicative of catheter colonization.   
Catheter related infection 
The yield of > 15cfu from a catheter by means of semiquantitative culture 
or a yield of  > 102 from a catheter, by means of quantitative culture with 
accompanying signs of local or systemic infection, is indicative of CRI.  
Catheter related blood stream infection:  
          The isolation of the same organism from a quantitative culture of the 
distal segment of the catheter and from the blood of a patient with clinical 
symptoms of sepsis in the absence of any other noticeable source of infection.  
 Inclusion Criteria 
a) Adult inpatients undergoing hemodialysis, who develop signs of 
inflammation at different sites like Jugular, Femoral and Subclavian 
catheterization after 48 hrs of insertion of catheter.   
b) Patients who develop fever, chills, headache, abdominal pain, 
diarrhea and hypotension and any other signs and symptoms suggestive of 
infection any time after 48hrs of insertion of  central venous catheter during 
hospitalization. 
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EXCLUSION CRITERIA 
a) Patients who have fever, chills, head ache and signs of inflammation        
within 48 hrs of insertion of catheter or prior to dialysis  
b) Patients in whom blood culture was positive before dialysis  
c) Patients with AV fistula or AV graft  
DATA COLLECTION 
Data collection included name, age, address, date of admission, diagnosis at 
admission, physical examination finding. Duration of hospital stay, nutritional status, 
underlying illness like  diabetes mellitus, uremia, hypertension, history of previous 
dialysis, infection during last dialysis, blood transfusion, type of catheter, duration of 
catheterization and concurrent other infections were recorded. 
STATISTICAL ANALYSIS 
Statistical analyses were carried out using Statistical Package for Social 
Sciences (SPSS) and Epi-Info softwares by a statistician. The proportional data 
of this cross sectional study were tested using Pearson’s Chi Square analysis test, 
Fisher exact probability test and Binomial proportion test.   
SAMPLE COLLECTION AND PROCESSING 
The following samples were collected 
 Catheter tip   
 Peripheral venous blood  
 Catheter blood ( catheter in situ) 
 Swab from  infected site of catheter 
 Stool 
 Urine 
 Sputum 
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CATHETER TIP[57] 
Catheter Removal Technique 
The skin exit site was inspected for evidence of local infection. Area was 
cleaned with  70 % isopropyl alcohol and allowed to dry. The catheter was then 
clamped with sterile Spencer well Forceps as close to skin as possible.  
The catheter was sectioned distally with sterile blade and carefully 
removed avoiding skin contact and placed in a sterile test tube and transported 
to the laboratory. The catheter was cut into three segments and used for 
quantitative and semiquantitative culture.  
One segment of the catheter was immersed in trypticase soy broth and 
another segment was used for roll plate method. The third segment was used 
for endoluminal washing method. 
Gram Staining of Impression Smear of Catheter Tip [2,27,53,98] 
A shallow narrow line of sterile saline solution was made along centre of 
long axis of glass slide with pasteur pipette. The catheter was removed from 
transport container by inserting microbiological straight wire into lumen. The 
external surface of catheter segment was rotated on the spot in line of saline 
solution by rotating handle of straight wire between index finger and thumb and 
attempting to keep the saline solution as narrow as possible. A zigzag manner 
along the long axis of slide was also used to dislodge as much as material as 
possible from outside of catheter. Slides were air dried, heat fixed and stained by 
Gram Stain method and examined by conventional light microscopy under oil 
immersion. 
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Semi quantitative Culture of Catheter  [2] 
Roll plate method [2,27,52,] 
First segment of the catheter 2 cm long was transferred on to the 
surface of a 5 % sheep blood agar and using sterile forceps or swab. The   
catheter segment was rolled  across the plate back and forth  about four times 
and incubated at 370C for 48hrs.  
Colonies on the plate were enumerated, identified and expressed in colony 
forming units (CFU). A colony count of 15 colonies or greater was considered as 
positive culture and less than 15 colonies was taken as contamination. These 
colonies were identified using various biochemical reactions.  
Interpretation 
12-24 hrs- If no growth after 24 hours the culture was reported as NO 
GROWTH. If >15 colonies suggested as local catheter infection. If < 15 
colonies not infection and suggestive of contaminated. Declare the result with 
antibiotic susceptibility after 48 hours.  
Vortex Method [2,23,26], 
In a sterile test tube middle segment of the catheter was placed inside 
the trypticase soy broth and vortexed in a vortex shaker machine for 1 minute. 
0.1 ml of the suspension was streaked onto sheep blood agar plate and 
incubated at 370C. If no growth on the plate was evident, the broth was 
observed for turbidity and subcultured every 72 hrs upto 10 days . If turbidity, 
or haemolysis was noted in the bottles, subcultures were done into Blood 
Agar, MacConkey Agar and Sabouraud’s Dextrose Agar Slope.  
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Interpretation 
 > 100 CFU/ml  for catheter segment was considered as significant.  
Segment washing (or) Endoluminal Flush Technique [56] 
1 ml of sterile saline was flushed into the lumen of the catheter 
segment using a sterile syringe into a sterile vial. 0.01ml of suspension was 
streaked on to 5% sheep blood agar and MacConkey agar and incubated at 
370C in CO2 for quantification. >100 CFU/ml for catheter segment was 
considered as significant 
COLLECTION OF BLOOD 
Blood was drawn before the use of antibiotics.  The venipuncture site was 
prepared with soap and water. Rinsed with sterile water, applied 1-2% 
tincture of iodine or povidone iodine or 70% isopropyl alcohol which will kill 
the surface and subsurface bacteria. The surface the skin was cleaned in a 
concentric manner and allowed to dry. 21ml of blood was drawn under aseptic 
precaution. 
 BLOOD FROM CATHETER: (CATHETER IN SITU) 
Qualitative Culture of Catheter Blood 
Under aseptic precaution The Luer lock of the catheter was removed, 
the first 5m1 of the aspirated blood from each catheter was discarded and then 
12m1 of blood was aspirated of which 10 ml was inoculated aseptically into 
BHI broth and 2ml of blood was added into trypticase soy broth and incubated 
under standard conditions. 
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Quantitative Culture of Catheter Blood 
One ml of sterile blood was collected aseptically with syringe from the 
catheter and mixed with 19 ml of melted nutrient agar base at 46°C and 
poured into sterile 9 cms petridish. The plates were rotated to distribute blood 
uniformly and left to solidify and incubating aerobically at 37°C for 48 hours. 
The colony count of > 100 colonies / ml was considered significant.  
BLOOD FROM PERIPHERAL VEIN  
1. Qualitative Culture of Peripheral Blood [2,23] 
The site for venipuncture  identified and tourniquet was applied. The 
skin was prepared exclusively with 70 % isopropyl alcohol then swabbed 
concentrically and 21 ml blood was collected using a sterile disposable 
syringe and needle.  
 10 ml was added aseptically into brain heart infusion broth (BHI) and  10 ml 
was added into trypticase soy broth. The remaining 1 ml of blood was used 
for quantitative culture. After collection the ratio of blood to medium should 
be 1:10.  The contents are mixed well for uniform distribution. The BHI broth 
and trypticase soy broth were incubated at 37°C aerobically and examined 
daily for a period of ten days. If turbidity, or haemolys is was observed in the 
bottles, subcultures were done into Blood Agar, MacConkey Agar and 
Sabouraud’s Dextrose Agar Slope. The plates were incubated at 37°C 
aerobically for 48 hrs and observed for growth. 
Quantitative Culture of Peripheral venous Blood[2] 
One ml of sterile blood which was collected aseptically was added to 
9cms sterile petridish which contains l9ml of previously melted Nutrient agar 
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base at 46°C. The plates were rotated to distribute blood uniformly and left to 
solidify before incubating it aerobically at 37° C for 48 hours. Once colonies 
were seen, they were counted accordingly and when the count was greater 
than 100cfu/ml it was considered significant.  
Collection of Swab [3] 
Any  purulent discharge, serous or serosanguinous discharge from the 
catheter site has been swabbed by using sterile swab. Two swabs were 
collected in a sterile test tubes and transported immediately to the laboratary. 
One swab was subjected to Gram stain and another for culture on 5% sheep 
blood agar and MacConkey agar. 
Collection of stool [59] 
Sterile wide mouth container with spatula was used for collection of 
liquid and semisolid stool and transported immediately and examined for wet 
mount, iodine mount and modified acid fast staining using 1% sulfuric acid. 
Enriched with Selenite F broth also plated directly on MacConkey agar. If 
growth of non lactose fermenting colonies observered it would be further 
subcultured on Xylose lysine deoxycholate agar and Deoxycholate citrate 
agar. 
Collection of Urine  [60] 
Clean catch midstream urine was collected in a sterile container after 
proper instruction and transported to the laboratory immediately. Direct 
Grams staining and Quantitative culture on MacConkey and 5% Sheep blood 
agar was done. A colony count of >105 was considered significant. 
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Collection of sputum:[60] 
 After through washing of mouth with water well expectorated early 
morning sputum sputum was collected in a wide mouth sterile container and 
transported immediately the laboratory. Sputum was treated with equal volume 
of 4% sodium hydroxide. Direct Grams staining, 10% Pottosium hydroxide 
mount , Ziehl Neelsen staining, Modified acid fast staining was done. 
PROCESSING OF SPECIMEN 
Gram Staining Procedure 
Thin smear of the specimen was prepared on a clean sterile glass slide. 
Then the smear was fixed by heating over a bunsen burner flame. The smear 
was flooded with 1% methyl violet for 1 minute and washed with distilled 
water. The smear was flooded with gram’s iodine for 1 minute and washed 
with distilled water and decolorized with acetone, washed with distilled water 
and counter stained with dilute carbol fuschin for 30 seconds  
Wet Mount 
In a clean glass slide about 2 mg of faeces was mixed with a drop of 
saline, cover with a coverslip and examined under low and high power for 
trophozoites and cysts. 
Iodine mount  
In a clean glass slide small quantity about  2mg of stool was mixed 
with a drop of Lugol’s iodine, cover with a coverslip and examined under low  
and high power for eggs.  
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 KOH Wet Mount 
A clean glass slide was taken. The specimen was placed in the centre 
of the slide. A drop of 10% KOH was added and a coverslip was placed over 
that, observed under low and high power microscope.  
 Peripheral smear 
Tip of the finger was cleaned with 70% alcohol and allowed to dry. 
One drop of capillary blood was drawn by finger prick using sterile needle 
and thin smear was prepared.   
Giemsa Staining 
Air dry and fix the smear with absolute methanol for 2-3 minutes. Stain 
the slide with Giemsa stain for 30 minutes. Air dry the slide and observe 
under the oil immersion microscope. 
Ziehl Neelsen staining 
          Smear was prepared on a clean glass slide and allowed to dry in the air. 
The smear was heat fixed over a Bunsen burner flame. The smear was flooded 
with strong carbol fuschin stain for 5 - 8  minutes with intermittent heating 
without boiling. The smear decolourized with 20% sulfuric acid and 
counterstained with loeffler’s methylene blue for 1-2 minutes.  
 Modified Acid Fast Staining 
Thin smear of the specimen was prepared and dried in the air. The 
smear was fixed by heating over a Bunsen burner flame. The smear was 
flooded with strong carbol fuschin stain for 5 minutes. Washed with distilled 
water and flooded with 1% sulphuric acid for 3 minutes. Washed with 
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distilled water and counter stained with 3% methylene blue for 3 minutes. 
Washed with distilled water dried and examined under oil immersion 
microscope. 
CULTURE 
The samples were plated onto the following media. 5% sheep blood 
agar, chocolate agar, Mac conkey agar, All the inoculated plates were 
incubated at 370C under aerobic condition and in a carbondioxide enriched 
atmosphere. Plates were evaluated for growth at 24 and 48 hours and 
discarded after five days except sabouraud dextrose agar which was kept for 4 
weeks. 
INTERPRETATION OF BACTERIAL CULTURE 
Interpretation isolates were identified by means of colony morphology, 
Gram staining, motility and biochemical reactions by standard microbiological  
techniques as recommended by clinical and laboratory standards institute 
(CLSI)  
After 24 hours of incubation, identification of bacteria was done by 
studying morphology of colony, gram stain, motility, catalase and oxidase 
tests. Single colony was taken and processed along with the controls. 
 Gram staining 
 Hanging drop 
 Oxidase test 
 Catalase test 
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 Coagulase test 
 Phosphatase test 
 IMVIC test 
 Nitrate reduction test 
 Urease test 
 TSI (Triple sugar iron agar) 
 Phenyl alanine deaminase test 
 O-F test 
 Sugar fermentation test 
 LAO decarboxylases test 
OXIDASE TEST    
1% tetramethyl - p - phenylene diamine dihydrochloride was prepared 
freshly with sterile distilled water. A filter paper circle was placed into a 
sterile petridish and moistened with several drops of the fresh reagent. A 
colony from a nutrient agar was taken with a sterile glass rod and rubbed onto 
the moistened filter paper along with controls. Appearance of dark purple 
colour within 10 seconds was considered as positive. 
CATALASE TEST  
Single colony from nutrient agar plate was picked with a sterile glass 
rod and inserted into 1ml of 3% hydrogen peroxide solution in a small clean 
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test tube. Immediate and sustained production of gas bubbles from the colony 
indicate positive reaction. 
COAGULASE TEST 
This was done to detect both free and bound coagulase enzymes.  
Slide coagulase test: 
Slide test is a rapid test to detect bound coagulase. Two drops of 
normal saline were placed in two circles drawn on a glass slide. Growth was 
taken from nutrient agar plate and emulsified into smooth suspension in two 
circles. Then one drop of undiluted plasma was added to one circle which was 
marked as test and the other circle as control without plasma. Visible 
clumping within 10 - 15 sec of mixing the plasma with the suspension was 
taken as positive. 
Tube coagulase test: 
This test detects free coagulase. A small amount of the colony growth  
of the organism is emulsified in a tube containing 0.5ml of coagulase plasma. 
Incubate the tube at 350C for 4 hours and observe for clot formation by gently 
tilting the tube. If no clot is observed at that time, reincubate the tube at room 
temperature and read again after 18 hours.  
INDOLE TEST 
Organisms were inoculated into Tryptophan broth and incubated a 
37°C for 18-24 hrs. 15 drops of Kovac’s reagent was added along the inner 
wall of the tube. Appearance of red ring over the surface was taken as 
positive. 
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METHYL RED TEST 
Organisms were inoculated into Glucose Phosphate broth and 
incubated at 37°C for 48-72hrs. Then 5 drops of Methyl red reagent was 
added to the broth. Appearance of red colour indicated positive result. 
VOGES-PROSKAUER TEST 
Organisms were inoculated into Glucose Phosphate broth and 
incubated at 37°C for 48-72 hrs. Then 0.6m1 of 5% alpha naphthol was 
added, followed by 0.2ml of 40% KOH. The tube was gently shaken without 
cotton plug to expose the medium to atmospheric oxygen and was read after 
10-15 minutes. Development of red color within 15 minutes was taken as 
positive. 
CITRATE UTILIZATION TEST 
A well isolated colony is picked from the surface of a primary isolation 
medium and inoculated as a single streak on the slant surface of the citrate 
agar tube. The tube is incubated at 350C for 24 to 48 hours. The test is 
positive if there is development of a deep blue colour within 24 to 48 hours, 
indicating that the test organism has been able to utilize the citrate contained 
in the medium. 
NITRATE REDUCTION TEST  
Nitrate broth was inoculated with test organisms and incubated at 37°C 
for 24 - 48 hrs. 5 drops of each reagent A(α naphthylamine) and reagent B 
(sulfanilic acid) were added to the broth. Red color developed within few 
minutes indicating the presence of nitrite .  
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UREASE  TEST 
The entire slope of the Christensen’s medium was inoculated with test 
organisms and incubated at 37°C for 24 - 96 hrs. Urease producing organisms 
changed the colour of medium to purple pink. 
SUGAR FERMENTATION TESTS 
Sugar fermentation test media containing different sugars  in the 
concentration of 1%, with inverted Durham’s tubes were inoculated with test 
organisms, and incubated at 37°C and observed for up to 1 week. Change of 
colour to yellow indicated that the sugar was fermented. Presence of gas in 
Durham’s tubes indicated gas production. 
O-F TEST  
 Two tubes of Hugh - Leifsons test media were stab inoculated with 
test organisms. One tube of this pair was covered with a 1cm layer of liquid 
paraffin and the other tube was left open to air. Both tubes were incubated at 
37°C and examined daily for up to 7 days. Appearance of yellow color in 
open tube and green color in covered tube indicated oxidative utilization of 
the sugar. 
TRIPLE SUGAR IRON TEST  
The organism was stabbed into butt and streaked onto the surface of 
slant, incubated at 37°C overnight. The next day change of color, H 2S 
production and presence of gas were noted. 
PHENYL ALANINE DEAMINASE TEST  
The medium containing phenyl alanine deaminase was inoculated 
heavily with test organism, incubated at 37°C overnight. Next day few drops 
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of 10% solution of ferric chloride was allowed to run down over the growth. 
Appearance of green color in the fluid and in the slope indicated positive test.  
PHOSPHATASE TEST 
Organism was grown on phenolphthalein diphosphate agar (consist of 
l000ml of nutrient agar and l0ml of 1% aqueous solution of sodium 
phenolphthalein diphosphate) at 37°C overnight. Next day few drops of liquor  
ammonia was poured on lid and plate was inverted over the lid. Colonies 
turned to bright pink, from yellow color within a few minutes, due to 
liberation of free phenolphthalein by the action of phosphatase was 
considered as positive. 
LAO DECARBOXYLASES TEST 
A well isolated colony of the test organism was inoculated into two tubes of 
Moeller decarboxylase medium, one containing the aminoacid to be tested,  
the other was used as control  devoid of aminoacid. The tubes were overlaid 
with sterile liquid paraffin and incubated at 350c for 18 to 24 hours. 
Conversion of the control tube to yellow colour and reversion of the tube 
containing the aminoacid to a blue purple colour indicated positive test. The 
specific amine products were 
Lysine – cadaverine 
Ornithine – putrescine 
Arginine - citrulline  
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INTERPRETATION OF FUNGAL CULTURE 
Inoculated SDA slants were incubated at 250C and 350C for minimum 
of 4 weeks before discarding as negative. These slants were inspected daily 
during the first week and twice weekly during the next three weeks for 
growth.  
Identification of filamentous fungi was done by preparing Lacto Phenol 
Cotton Blue mount and studying the morphology of hyphae and conidial 
arrangement. In difficult ambiguous cases where sporulation was inadequate, 
Riddle’s slide culture technique was performed.  
In case of yeasts, identification and specification was done by Gram’s 
stain morphology, germ tube test, Chrome agar and biochemical tests by 
standard microbiological techniques as recommended by CLSI.  
Examination of Sabouraud’s dextrose agar Media:  
The colonies were observed for growth in the Sabouraud’s dextrose 
agar slopes and noted the description, if it was inadequate reincubated and 
examined daily during first week and twice a week for next 3 weeks. Failure 
of growth after 6 weeks was considered as negative for fungal growth and is 
to be discarded. 
 Germ tube test (Reynolds-Braude Phenomenon) 
          Suspension of test organism in 0.5ml of sterile serum (plasma, egg 
albumin or peptone media) and incubated at 37oC for 2 hours. A drop from 
incubated serum placed on the slide with coverslip and observed under 
microscope for germ tubes 
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 Lactophenol cotton blue stain 
The fungal growth was taken from Sabouraud’s dextrose agar slope 
with spud and transferred onto the clean glass slide and two to three drops of 
Lactophenol cotton blue reagent was added over the fungal growth. By using 
teasing needles the growth was spread over the slide and coverslip was placed  
without trapping any air bubbles. The morphology of hyphae, conidia were 
observed under microscope and was correlated with macroscopic features.  
Chrom Agar 
The species of candida can be identified by different coloured colonies 
produced due to the reaction between specific enzymes of the different 
species and the chromogenic substrates in the system, which are as follows:  
 C.albicans - light green 
 C.dubliniensis -  dark green 
 C.glabrata - pink to purple 
 C.krusei - pink 
 C.parapsilosis - cream to pale pink 
 C.tropicalis -  blue with pink halo 
Sugar Fermentation: 
Biochemical tests like sugar fermentation was done for identification 
of yeast isolate Glucose, Maltose, sucrose, Lactose, Galactose and Trehalose 
sugars (2%) were used. The colour change in the tube containing the 
particular sugar indicates the yeast’s ability to ferment carbohydrate.  
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Slide culture  
The slide culture was performed using isolates. The slide culture is 
used to study undisturbed morphology details particularly relationship 
between reproductive structure like conidia, conidiophores and hyphae. 
Fungal slide culture was performed in cases with doubtful morphology.  
ANTIMICROBIAL SENSITIVITY TESTING: 
Antibiotic susceptibility testing was performed by the Kirby Bauer disc 
diffusion method on Mueller Hinton agar according to Clinical Laboratory 
Standards Institute protocols. The diameters of zones of inhibition were 
interpreted according to CLSI standards for each organism. Culture media and  
antibiotic discs were tested for quality control using standard ATCC strains. 
The following standard strains were used 
1. Staphylococcus aureus-ATCC 25923 
2. Escherichia coli-ATCC 25922 
3. Pseudomonas aeruginosa-ATCC 27853 
The panel of antibiotics included in the antimicrobial sensitivity testing for  
GNB 
Ciprofloxacin, Cefotaxime, Amikacin, Garamycin, Ofloxacin, Norflox, 
Nitrofurantoin, Cotrimoxazole, Imipenam, Piprazine Tazobactum, Ceftazidime. 
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GPC 
Cirofloxacin, Cephalexin, Amikacin, Erythromycin, Cotrimoxazole, 
Oxacillin, Penicillin, Amoxycillin, Cephelexin, Ciprofloxacin. Vancomycin, 
Amoxycillin clavulinic acid 
PROCEDURE OF KIRBY-BAUER DISC DIFFUSION TEST 
1) With a wire or a loop touched the surface of 5 similarly appearing 
colonies on an agar plate culture. Transferred the growth to a tube 
containing a suitable broth medium. 
2) Allowed the culture to incubate at 350C until it matches the turbidity of 
0.5% Mc Farland standard. 
3) Dipped a sterile non-toxic cotton swab into the inoculum suspension 
and rotated the swab several times with firm pressure on the inside 
wall of the tube to remove excess of fluid.  
4) Inoculated the dried surface of a Mueller Hinton agar plate that has 
been brought to room temperature by streaking the swab 3 times over 
the entire agar surface rotating the plate approximately 60 degrees to 
ensure an even distribution. Replaced the lid of the dish. Allowed 3 to 
5 minutes but no longer than 15 minutes for the surface of the agar to 
dry before adding the antibiotic discs.  
5) Appropriate antimicrobial disc was placed on the surface of the agar             
using forceps. 
6)  Plate was incubated at 370 c overnight. 
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7) After overnight incubation, zone diameters was measured in mm from 
the edge of the disc to the zone edge with a ruled template on the agar 
surface 
Zone diameters were interpreted according to CLSI guidelines 
For gram negative bacteria, the following antibiotics were included in the 
antimicrobial sensitivity testing (Himedia) 
ANTIMICROBIAL 
AGENT 
DISC 
CONTENT 
ZONE DIAMETER IN 
mm 
S I R 
Amikacin 30 μg >17 15-16 <14 
Gentamycin 10μg >15 13-14 <12 
Cefotaxime  30μg >26 23-25 <22 
Ceftriaxone 30 μg >23 20-22 <19 
Ceftazidime 30μg >21 18-20 <17 
Ciprofloxacin 5 μg >21 16-20 <15 
Ofloxacin 5 μg >16 13-15 <12 
Imipenem 10μg >23 20-22 <19 
Norfloxacin  10 μg >17 13-16 <12 
Nitrofurantoin 300 μg >17 15-16 <14 
Piperacillin-tazobactam 100/10 μg >18 - <17 
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For Pseudomonas 
ANTIMICROBIAL 
AGENT 
DISC 
CONTENT 
ZONE DIAMETER IN mm 
S I R 
Ceftazidime 30μg >18 15-17 <14 
Imipenem 10μg >16 14-15 <13 
Piperacillin-tazobactam 100/10 μg >18 - <17 
 
For gram positive cocci, the following antibiotics were included in the 
antimicrobial sensitivity testing (Himedia) 
ANTIMICROBIAL 
AGENT 
DISC 
CONTENT 
ZONE DIAMETER IN mm 
S I R 
Amikacin 30 μg >17 15-16 <14 
Amoxicillin-clavulanic 
acid 
20/10 μg >18 14-17 <13 
Oxacillin 1 μg >13 11-12 <10 
Cefoxitin  30 μg >22 - <21 
Ciprofloxacin 5g 15 16-20 21 
Ofloxacin 5 μg >18 15-17 <14 
Erythromycin 15 μg >23  <13 
Cotrimoxazole 1.25-23.75g >10 11-15 >16 
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DETECTION OF BETA LACTAMASE ENZYME 
PRODUCTION IN GRAM NEGATIVE BACILLI: 
A) Extended Spectrum  Beta Lactamases (ESBL) Detection 
Methods: 
1. Screening method:[61] 
Isolates of gram negative bacilli showing the following resistance 
pattern were considered to be possible ESBL producing strains.  
Antibiotic Zone diameter for possible ESBL producing strain 
Ceftazidime (30g) <=22mm 
Cefotaxime (30g) <=27mm 
Ceftriaxone (30g) <=25mm 
Aztreonam (30g) <=27mm 
CLSI phenotypic confirmation test:[62,63] 
With a sterile bacterial loop 3-5 identical colonies were picked from a 
fresh overnight  culture and inoculated into 5 ml of nutrient broth. The broth 
was incubated at 35°C for 2-4 hrs and the turbidity matched with 0.5 
McFarlands standard. Lawn culture of the test organism was made on to 
Muller-Hinton Agar (MHA) plate. Antibiotic disc Ceftazidime (CAZ 30g) 
and Ceftazidime/Clavulanic acid (CAZ/ CA 30g/ l0g) were placed and 
incubated at 35°C overnight. A >5mm increase in zone diameter for 
Ceftazidime tested in combination with Clavulanic acid versus its zone when 
tested alone confirmed an ESBL producing organism. 
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Double disk diffusion synergy test: [64] 
In this test discs of third generation Cephalosporins and Clavulinic 
acid (20g/l0g) were kept 30mm apart from centre to centre on inoculated 
Muller-Hinton Agar. A clear extension of the edge of the inhibition zone of 
cephalosporin towards Clavulinic acid disc was interpreted as positive for 
ESBL production 
ESBL DETECTION BY E- TEST STRIP 
This combines both the principles of dilution and diffusion techniques. 
E strip is a thin non porous plastic strip 5mm wide and 60mm long. It carries 
two shorter gradients aligned in opposing directions on a single strip. One end 
generates a stable concentration gradient of the one of the oxyimino 
cephalosporins (eg. ceftazidime), while the other end generates a gradient of 
cephalosporin + clavulanic acid (4g/ml). When applied to an inoculated agar 
plate inhibition ellipse may be seen on the both ends of the strip. MIC is 
interpreted as the point of intersection of the inhibition ellipse with E test 
strip edge. Ratio of cephalosporin MIC and cephalosporin clavulanic acid 
MIC >8 indicates positive result. 
AMPC  LACTAMASES DETECTION METHODS: 
1. Screening method:[65] 
A 0.5 Mcfarland of the test isolate was swabbed on MHA plate and 
disc of Cefotaxime (30g), Ceftazidime (30g) were placed adjacent to 
Cefoxitin (30g) disc at a distance of 20 mm from each other. After 
incubation, isolates showing blunting of Ceftazidime or Cefotaxime zone of 
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inhibition adjacent to Cefoxitin disc or showing reduced susceptibility to 
either of the above drugs and Cefoxitin were considered as screen positive 
and selected for detection of AmpC  lactamases 
2. AmpC Disc test:[65] 
A lawn culture of E.coli ATCC 25922 were prepared on MHA plate. 
Sterile discs (6 mm) were moistened with sterile saline (20l) and inoculated 
with several colonies of test organism. The inoculated disc was then placed 
beside a Cefoxitin disc (almost touching) on the inoculated plate. The plates 
were incubated overnight at 35°C. A positive test appeared as a flattening or 
indentation of the Cefoxitin inhibition zone in the vicinity of the test disc. A 
negative test had an undistorted zone, 
METALLO BETE LACTAMASES (MBL) DETECTION 
METHODS: 
Imipenem- EDTA disc method:[66] 
A l0g imipenem disc  containing 750 μg of EDTA solution was used. 
The inhibition zone with imipenem-EDTA disc were <19 mm for the MBL 
negative isolates and >23 mm for MBL positive isolates. 
Imipenem- EDTA combined disk test: [67] 
The test organism was inoculated onto MHA plate. Imipenem (10g) 
and l0g Imipenem disc containing 750pg of EDTA solution were placed on 
the plate and incubated overnight. If the increase in inhibition zone  with 
Imipenem- EDTA disc is >7mm than the Imipenem disc alone, it was 
considered MBL positive. 
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DETECTION OF METHICILLIN RESISTANCE IN 
STAPHYLOCOCCUS AUREUS: 
Disc diffusion method:[68,69] 
Colonies isolated from agar culture plate were suspended directly into 
broth, vortexed to reach 0.5Mcfarlands standard. A lawn culture of the 
Staphylococcal colonies was made on the MHA plate and Cefoxitin 30g disc 
was applied. Incubated was at 350C for 24 hours in ambient air. According to 
CLSI criteria with 30g cefoxitin disc diameter of <21 or >22mm 
corresponded to resistant or susceptible to cefoxitin. 
Minimum inhibitory concentration (MIC) for detecting 
Vancomycin resistance:[70] 
1. Culture media: cation adjusted Mueller Hinton broth.  (pH 7.2-7.4)  
2. Preparation of stock antibiotic solution:  
Antibiotic stock solution can be prepared using the formula  
= 1000/p x VxC=w 
Where p= potency of the antibiotic in relation to the base. (For 
vancomycin, p 950/1000 mg; Himedia) 
V = volume of the stock solution to be prepared (l0ml)  
C = final concentration of the antibiotic solution (1024g/ml) 
W = weight of the antibiotic to be dissolved in the volume V 
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Scheme of preparing dilution of antibiotics 
 Arrange two rows of sterile test tubes in the rack (1 row for the test 
& 2nd for ATCC control) 
Using sterile syringe transfer 2m1 of MH broth to the sterile container 
containing the working stock solution (128g/mI concentration) from this 
transfer 1 ml to the first tube in each row. 
 Now we have 2m1 of the diluted antibiotic in the sterile container. Using 
syringe add 2ml of MH broth to the 2m1 of left over antibiotic in the 
sterile container, mix and transfer 1 ml to second tube in each row.  
 Repeat this procedure till the 8th tube 
 Place 1 ml of the antibiotic free broth in the last tube in each row (growth 
control) 
 The sterility controls for the antibiotic solution is kept 
4. Inoculum preparation for the test and ATCC control and 
incubation 
 Take 9.9 ml of MH broth in a sterile container. 
 Add 0.1 ml of 0.5 Mcfarland turbidity matched test organism broth . 
 Mix well, transfer 1 ml of inoculum using 2 ml syringe to each tube 
containing antibiotic dilutions and also to the control tube.  
 Similarly repeat the procedure for ATCC control strain. 
 Incubate the rack at 37°C – overnight. 
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 Observe the MIC of ATCC control strain, If it is out of the sensitive range, 
the test is invalid. 
 Read for the test organism 
 The lowest concentration of the antibiotic in which there is no visible 
growth will be the MIC for the drug & for the test organism 
 MIC <2mg/ml – SENSITIVE- Staphylococcus aureus 
ANTIFUNGAL SUSCEPTIBILITY TESTS 
As per the guidelines of CLSI, the test was performed. MIC of water 
soluble drug Fluconazole and water insoluble drugs Amphotericin-B, 
Itraconazole and Voriconazole were determined. 
BROTH DILUTION METHOD  
Preparation of stock solution 
Weight (mg) = volume (ml) x concentration (g/ml)/Assay Potency  
Incolum preparation  
The isolateion were subcultured on SDA, fresh culture of 24 hours 
colonies were taken 0.5 Mc Farland standard inoculum was prepared and 
diluted upto 1:20 with normal saline. The final inoculum was prepared. The 
Suspension was mixed for 15 minutes for turbidity adjusted ether visually or 
with a spectro photometer by adding sufficient sterile saline (or) adding more 
colonies and to match with 0.5 Mc Farland at 530 nm wave length with the 
optical density of 0.09 to 0.11.  
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Stock solution for water soluble drugs- 5120 g/ml   
Stock solution for water insoluble drugs – 1600 g/ml 
Media used- RPMI 1640. Varying concentrations of the drugs were 
tested. 
Amphotericin B 0.0313 to 16g/ml 
Fluconazole 0.125 to 64g/ml 
Itraconazole and Voriconazole 0.0313 to 16g/ml 
Preparation 
Dimethyl sulfoxide (DMSO) was used to dissolve Amphotercin B, 
Itraconazole and voriconazole. The DMSO, the series of dilution at 100 times 
the final concentration were prepared from the Antifungal stock solution.  
         ATCC Candida albicans 90028 and ATCC Aspergillus flavus 204304 
was used for quality control of the test. The broth microdilution test was 
performed by using sterile, disposable, multiwell microdilution plates (96U- 
shaped wells). 100l of varying drug concentrations was dispensed in each 
rows from 1 to 10. 100l of inoculum was also dispensed. Incubated at 350C 
for 48 hours. 
INTERPRETATION: 
Minimum inhibitory concentration was as defined as  the lowest drug 
concentration that showed 100% inhibition of the growth compared to growth 
control well.  
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The test was read in comparison with growth control and antibiotic 
control. The adequate inhibition (or) clearance of growth after 24-48 hours 
was taken as MIC.  
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RESULTS 
TABLE 1: DISTRIBUTION OF AGE & SEX IN THE STUDY 
GROUP (n=150) 
Age in yrs 
Male 
n =78          (52%) 
Female 
n =72          (48%) Total  
no (%) 
No. % No. % 
18-20 2 2.6 4 5.6 6 (8.2%) 
21-30 32 41.0 19 26.4 51 (67.4%) 
31-40 19 24.4 11 15.3 30 (39.0%) 
41-50 15 19.2 25 34.7 40 (53.9%) 
51-60 8 10.2 7 9.7 15 (19.9%) 
61-65 2 2.6 6 8.3 8 (8.9%) 
78 males and 72 females were included in the study. Majority of the 
patients (67.4%) in the study group belonged to the age group of 21-30 years 
and highest percentage of cases (41%) seen in males of age group between 
21-30 and in females(34.7%) seen in 41- 50 yrs of age group. 
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Fig1: Distribution of Age and Sex 
62 
 
TABLE 2: TYPE OF RENAL DISEASE IN THE STUDY 
GROUP (n=150) 
Diagnosis No. % 
Chronic Kidney Disease(CKD) 106 70.7 
Acute Kidney Injury(AKI) 44 29.3 
Majority of cases undergoing hemodialysis had CKD 70.7%, followed 
by AKI 29.3%  
Diagnosis
71%
29%
Chronic Kidney Disease(CKD) Acute Kidney Injury(AKI)  
Fig 2: Diagnosis  
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TABLE 3: INDICATION FOR HEMODIALYSIS IN THE 
STUDY GROUP (n= 150) 
Acute Kidney 
Injury 
No % Chronic Kidney Disease No % 
 Medical renal 
disease 
 < 3months 
22 50.0 Diabetes Mellitus 37 35.0 
Acute diarrheal 
disease  
7 16.1 Hypertension  34 32.0 
Snake Bite  3   6.8 Post renal transplant failure 15 14.2 
Postpartum  3 6.8 End Stage Renal 
Diseases(ESRD) 
8 7.5 
Post surgical  3 6.8 Anaemia with Failure  4 3.9 
Drug induced 2   4.6 Nephrotic Syndrome 3 2.8 
Copper Sulphate 
poisoning  
2 4.6  Systemic lupus   
erythematosis 
3 2.8 
Hemolytic Jaundice   1 2.2 Hemolytic uremic 
syndrome 
1 0.9 
Hydronephrosis 1 2.2 Renal artery stenosis 1 0.9 
Total 44 29.3% Total 106 70.7% 
The predominant cause among patient with CKD was Diabetes 
mellitus(35%), followed by Hypertension(32%). 14.2% patients had post renal 
transplant failure. Among the 44 of AKI   50% had Medical renal disease less 
than 3 months and 16.1% had acute diarrheal disease.  
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Fig 3: Acute Kidney Injury 
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Fig 3(a): Chronic Kidney Disease 
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TABLE 4: DISTRIBUTION OF SAMPLES 
COLLECTED FROM STUDY GROUP AND THEIR 
CULTURE POSITIVITY  
Samples  Aerobic Bacteria Fungi Parasites 
Catheter tip         (n= 150) 88 (58.3%) 7 (4.6%) - 
Peripheral venous blood  (n= 150) 35 (23.3%) 3 (2%)  
Central venous catheter blood   (n=9) 6 (66.6%) - - 
Swab from Infected Site  (n=12) 4 (33.3%) - - 
Urine  (n=33) 11 (33.3%) 8 (24.2%)  
Sputum  (n=15) 6 (40%) - - 
Stool                      (n=20) - - 13 (65%) 
Catheter tip and peripheral venous blood was collected from all the 
cases. Central venous catheter blood sample was collected in 9 cases along 
with the peripheral blood. None of the cases with urinary infection or upper 
respiratory  infection had a positive culture in peripheral venous blood.  
58.3% and 23.3% of Aerobic bacteria were isolated from catheter tip 
and peripheral venous blood samples respectively. Fungi isolated from 2% of 
peripheral venous blood samples and 24% of urine samples. Parasitic 
infections was noted in 65% of patient with gastrointestinal symptoms.  
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Fig 4: Distribution of samples collected from study group and 
their culture positivity 
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TABLE 5: DIRECT GRAM STAINING OF CATHETER TIP 
Findings Number Percentage 
Gram Positive Organism with pus cells 27 18.0 % 
Gram Negative Organism with pus cells  11 7.4% 
Presence of Polymorphs 35 23.3 % 
No specific findings 77 51.3 % 
Gram staining demonstrated Gram positive cocci in 18% and Gram 
negative bacilli in 7.4% of cases. Polymorphs were seen in 23.3% catheter samples 
TABLE 6: CULTURE POSITIVITY OF CATHETER TIP BY 
VARIOUS CULTURE METHODS (n=150) 
Micro organism Roll Plate Method Vortex 
Segment 
Washing 
Culture Positive  88(58.7%) 71(47.4%) 28 (18.7%) 
No Growth 62(41.3%) 79(52.6%) 122(81.3%) 
Maximum culture positivity was observed in roll plate method 88 
(58.7%), Compared to other methods like Vortex and segment washing which 
showed 71(47.4%) and 28(18.7%) of culture positivity respectively.  
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fig 5: Culture positivity of catheter tip by various culture methods 
(n=150) 
TABLE 7: QUANTITATIVE BACTERIAL CULTURE OF 
CATHETER TIP & PERIPHERAL VENOUS BLOOD 
Colony Forming Unit/ ml Catheter tip Peripheral Blood  
Nil Count 62 (41.3%) 115 (76.7%) 
> (10)2 col/ml       88 (58.7%) 35 (23.3%) 
Among the positive culture in catheter tip and peripheral blood colony 
count of  > 102cfu/ml was  observed in 88 cases (58.7%) and 35 cases (23.3%) 
respectively.  
Chisquare value = 38.707,  p<0.05 - statistically significant  
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TABLE 8: CATEGORIZATION OF CATHETER RELATED 
INFECTION 
Catheter related Infection Number  Percentage  
Catheter related infection without positive blood 
culture 
53 35.3 % 
Catheter related infection with positive blood 
culture 
35 23.3% 
Negative culture for both catheter and peripheral 
venous blood 
62 41.4 % 
 Among the 88 catheters processed 53(35.3%) was catheter culture 
positive but blood culture negative, hence categorized as catheter related 
infection(CRI). But 35 cases (23.3%) was positive for both catheter and blood 
culture and showed similar growth in both, therefore categorized  as  Catheter 
related blood stream infection(CRBSI).  
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fig 6: categorization of Catheter related infection 
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TABLE 9: CORRELATION OF CRBSI WITH AGE 
Age in years 
No.of Cases 
 
Positive cultures 
 
Percentage of 
positive 
culture 
18-20 6 1 16.6 
21-30 51 14 27.4 
31-40 30 6 20.0 
41-50 40 7 17.5 
51-60 15 5 33.3 
>60 8 2 25.0 
CRBSI was noted most commonly in the age group of 51-60 years 
(33.3%) followed by 27.4% between 21-30 yrs.  
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fig 7: Correlation of catheter related blood stream infection with 
age 
70 
 
TABLE 10:  ASSOCIATION BETWEEN SITE OF 
CATHETERIZATION AND CRBSI 
Site No.of Cases Positive cultures Percentage 
Internal Jugular vein 144 30 20.8 
Subclavian vein 3 2 66.6 
Femoral vein 3 3 100 
The commonest site of central venous catheterizat ion was the internal 
jugular vein. CRBSI was detected in 20.8% of these catheters. Femoral 
venous catheterization was done in very few patients and they have the higher 
risk of developing CRBSI. 
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fig 8: Association between site of Catheterization and CRBSI 
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TABLE 11: CORRELATION BETWEEN NUMBER OF 
DIALYSIS AND POSITIVE AEROBIC BACTERIAL 
CULTURES IN CRBSI 
Number of 
dialysis No.of Cases Positive cultures 
Percentage of 
positive 
culture 
1-5 96 9 9.3 
6-10 29 12 41.3 
>10 25 14 56.0 
As the number of dialysis increased, the culture positivity also 
increased. Patients underwent HD more than 10 times showed  56 % of 
Catheter related blood stream infection.  
Chisquare =30.648, p<0.05 - statistically significant. 
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fig 9: Correlation between number of dialysis and positive aerobic 
bacterial cultures in CRBSI 
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TABLE 12: ASSOCIATION BETWEEN DURATION OF 
CATHETERIZATION AND CRBSI 
Duration of Catheterization NO Percentage 
1-5 days 1 2.8 
6-10 days 4 11.4 
11-15 days 12 34.3 
>15 days 18 51.4 
The frequency of CRBSI was 51.4% in patients with catheter in place 
for >15 days followed by 34.3% when the duration was between11-15 days.  
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fig 10: Association between duration of catheterization and 
CRBSI 
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TABLE 13: TYPE OF PREDISPOSING FACTORS FOR CRBSI  
Diagnosis No of cases Percentage 
History of previous dialysis 31 88.5 
History of infection in previous dialysis 28 80.0 
Anaemia 32 91.4 
Diabetes Mellitus 33 94.2 
Hypertension              11 31.4 
Hepatitis C positive 1 2.8 
Among the 35 cases of CRBSI  predominant risk factor observed was 
diabetes mellitus 94.2%,followed by anaemia 91.4% . 
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fig 11: Type of predisposing factors of CRBSI 
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TABLE 14: DISTRIBUTION OF AEROBIC BACTERIAL 
ISOLATES FROM VARIOUS SAMPLES 
ISOLATE Catheter (n=88) 
Peripheral 
blood 
(n=35) 
Catheter 
blood 
(n=6) 
Urine 
(n=11) Stool  
Swab 
4 
Sputum 
6 
S.aureus MRSA 24 
(27.2%) 11 (31.4%) 2(33.3%)  -  
 
MSSA 5 (5.6%) 3 (8.5%) - - - 1 3 (50%) 
S.epidermidis 23 
(26.1%) 3 (8.5%) - 
3 
(27.2%) -  
 
S.warneri 2 (2.2%) - - - -   
S.schleiferi 2 (2.2%) 2 (5.7%) - - -   
Micrococcus Spp 4 (4.5%) - - - -   
Pseudomonas 
aeruginosa 7 (8.0%) 5 (14.2%) 
1 
(16.7%) - -  
 
Acinetobacter 
baumannii 8(9.0%) 4 (11.4%) 
3 
(50.0%) - -  
 
E.coli 4 (4.5%) 3 (8.5%)  8 (72.2%) - 
1 
(25%) 
 
K.oxytoca 3 (3.4%) 2 (5.7%)   - 2 (50%) 
 
K.pneumoniae 2 (2.2%) 1 (2.8%)   -  3 (50%) 
Proteus mirabilis 2 (2.2%) 1 (2.8%)   -   
Proteus vulgaris 2 (2.2%) -   -   
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 Staphylococcus aureus was the predominantly isolated gram positive 
cocci (GPC) from catheter and peripheral venous blood. Pseudomonas 
aeruginosa was the commonest gram negative bacilli isolated from 
catheter tip.  
 Methicillin resistance was noted among Staphyloccus aureus isolates in 
27.2% and 31.4% catheter tip and peripheral venous blood isolates . 
 33.3% MRSA, 16.7% Pseudomonas aeruginosa and 50% Acinetobacter 
baumannii isolated from catheter blood.  
 The commonest etiological agent in urinary tract infection was 
Escherichia coli (72.2%)  
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fig 12: Distribution of Aerobic Bacterial isolates from various 
samples 
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TABLE 15:  ETIOLOGICAL AGENTS OF CRBSI (n=35) 
Isolate CRBSI(35) 
S.aureus MRSA 11 (31.4%) 
MSSA 3 (8.5%) 
S.epidermidis 3 (8.5%) 
S.schleiferi 2 (5.7%) 
Pseudomonas aeruginosa 5(14.2%) 
Acinetobacter baumanii 4 (11.4%) 
E.coli 3 (8.5%) 
K.oxytoca 2 (5.7%) 
K.pneumoniae 1 (2.8%) 
Proteus mirabilis 1 (2.8%) 
Among the gram positive organism, predominant isolate was  31.4% of 
Methicillin resistant Staphylococcus aureus  followed by Methicillin sensitive 
Staphylococcus aureus (8.5%).Among the gram negative organism 
Pseudomonas aeruginosa was the etiological agent (14.2%), followed by 
Acinetobacter baumannii (11.4%). 
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8.50%
8.50%5.70%
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8.50%
5.70% 2.80% 2.80%
S. aureus MRSA
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E.coli
K.oxytoca
K.pneumonia
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fig 13: Etiological Agents of CRBSI 
TABLE 16: TYPE OF POLY MICROBIAL INFECTION IN 
CRBSI (n=35) 
Mixed Growth Catheter 
Staphylococcus aureus + Candida albicans 4 (11.4%) 
Staphylococcus aureus + Klebsiella oxytoca 2 (5.7%) 
Among the total of 6 cases of polymicrobial growth, Staphylococcus 
aureus and Candida species was isolated in 11.4% followed by 
Staphylococcus aureus and Klebsiella oxytoca in 5.7%. 
TABLE 17: CORRELATION OF CRBSI AND 
DEVELOPMENT OF COMPLICATIONS  
Complication No.of Cases Percentage 
Hypotension 4 11.4% 
Septic Thrombophlebitis  2 5.7 % 
Death 1 2.8 % 
Among the 35 cases of CRBSI, 11.4% developed hypotension and 
5.7% septic thrombophlebitis. Mortality was seen in 2.8% cases.  
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TABLE 18: TYPE OF FUNGAL ISOLATES FROM VARIOUS 
SAMPLES (n=18) 
Fungi Catheter tip Peripheral venous lood Urine 
C.albicans 2  (11.1) 1 (5.6) 4 (22.2) 
C.parapsilosis 1 (5.6) 1 (5.6) 1 (5.6) 
C.tropicalis 1 (5.6) 1 (5.6) 3 (16.6) 
Asp. Flavus 2 (11.1) - - 
Asp.fumigatus 1 (5.6) - - 
A total of 5.6% of C.albicans, C.tropicalis, C.parapsilosis  was isolated  
from blood. Aspergillus flavus was isolated only from catheter in 11.1% of 
cases and Aspergillus fumigatus in 5.6% of cases.  Among the 4 cases 
Candida species isolated from catheter 3 cases had candidaemia.  
11.10%
5.60%
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5.60%
5.6
5.60%
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Peripheral venous lood
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fig 14: Type of fungal isolates from various samples 
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TABLE 19: TYPE OF PARASITES FROM STOOL SAMPLE 
(n=13) 
Parasite No Percentage 
Entamoeba histolytica 6 46.1% 
Giardia lamblia 4 30.7% 
Cryptosporidium parvum 2 15.3% 
Microsporidia 1 7.6% 
Entamoeba histolytica was predominantly seen in 46.1%  of patients 
with gasterointestinal symptoms followed by Giardia 30.7% and 
Cryptosporidium parvum 15.3%. 
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Fig 15: Type of Parasites from Stool Sample
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TABLE 23: MIC OF VANCOMYCIN FOR 
STAPHYLOCOCCUS AUREUS 
Organism 
Minimum inhibitory concentration Break Point 
0.25 g/ml 0.5 g/ml 1.00 g/ml >2 g/ml 
S.aureus n=37 22 15 - - 
Among the 38 isolates of MRSA all were sensitive to vancomycin  with 
the MIC of <2. 
 TABLE 24: DETECTION OF ESBL PRODUCERS AMONG 
ZTHE GRAM NEGATIVE BACTERIA FROM VARIOUS 
SAMPLES 
 Number of positive isolates 
Pathogens Screening test DDST PCDDT 
Proteus mirabilis(n=3) 2 66.6% 1 33.3% 1 33.3% 
Escherichia coli (n=16) 7 43.75% 6 37.5% 6 37.5% 
Klebsiella pneumoniae (n=6) 3 50.0% 1 16.6% 1 16.6% 
Proteus vulgaris (n=2) 1 50.0% 1 50% 1 50% 
Klebsiella oxytoca (n=7) 2 28.5% 1 14.2% 1 14.2% 
PCDDT-Phenotypic confirmation disk diffusion test, DDST-Double 
disk diffusion synergy test.16.6% of Klebsiella pneumoniae,50% of Proteus 
vulgaris, 33.3% of Proteus mirabilis and 37.5% of Escherichia coli and 
14.2% of  Klebsiella oxytoca  were found to be ESBL producers.  
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TABLE 25: ANTI FUNGAL SUSCEPTIBILITY PATTERN OF 
CANDIDA ISOLATES  
Isolate No. of Isolates 
Fluconazole Amphotericin B 
Sensitive Resistance Sensitive Resistance 
MIC < 8 MIC>64 MIC <1 MIC>1 
Candida albicans  7 7 (100) -  7(100) - 
Candida 
parapsilosis 
3 3 (100) -  3(100) - 
Candida tropicalis 5 5 (100) -  3(100) - 
All the Candida isolates were 100% sensitive to Fluconazole and 
Amphotericin B .  
TABLE 26: ANTI FUNGAL SUSCEPTIBILITY PATTERN OF 
ASPERGILLUS SPECIES 
Isolate 
Amphotericin B Itraconazole Voriconazole 
Sensitive 
MIC<2 
Resistance 
MIC>2 
Sensitive 
MIC<8 
Resistance 
MIC>8 
Sensitive 
MIC<8 
Resistance 
MIC>8 
Aspergillus 
flavus 
(n=2) 
2 (100) - 2 (100) - 2 (100) - 
Aspergillus 
fumigatus 
(n=1) 
1 (100) - 1 (100) - 1 (100) - 
Asp.flavus and Asp.fumigatus showed 100% sensitive to Amphotericin 
B,  Itraconazole,  Voriconazole  
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DISCUSSION 
This study was conducted in the Institute of Microbiology is association with 
Department of Nephrology, Rajiv Gandhi Government General Hospital, Chennai.  
The analysis of catheter related sepsis in hemodialysis patients needs a 
careful microbiological evaluation to differentiate between, Colonization Catheter 
related infection (CRI) and Catheter related blood stream infection (CRBSI). The 
prime interest of this study was to evaluate the central venous catheter related 
bacterial and fungal infection associated with CRBSI and also to screen the other 
bacterial, fungal and parasitic infection in patients on hemodialysis. Careful 
monitoring and management of catheter related blood stream infection will in turn 
reduce the rate of occurrence of nosocomial infection in our tertiary care hospitals.  
None of the patients included in our study falls under the category of 
Colonization, as the specimens were collected only from symptomatic patients after 
hospitalization. 
In our study 150 adult inpatients who underwent hemodialysis through the 
central venous catheter with symptoms and signs of infection were taken. Majority of 
the study population were males (52%) and females (48%) with the ratio was 1.8:1. 
Majority (67.4%) were between the age group of 21-30yrs[Table1]. Hemodialysis was 
performed through central venous catheters in 70.7% of Chronic kidney diseases (CKD) 
and  29.3% of Acute kidney injury(AKI)  patients. [Table 2] Among the Chronic kidney 
disease patients(CKD) Diabetes Mellitus was the predominant underlying cause of 
catheterization in 35% 
 
86 
 
 
followed by hypertension 32%, post renal failure 14.2% and end stage renal 
disease in 7.5%.  Less than 5% contributed by anaemia with failure, nephrotic 
syndrome, hydronephrosis, hemolytic uremic syndrome and systemic lupus 
erythematosis.  In Acute kidney injury (AKI) medical renal disease less than 3 
months contributed 50% followed by 16% diarrhea, 6.8% snake bite, post 
partum, and post surgical causes.4.6% had history of poisoning and 2.2% had 
hemolytic anaemia.[Table 3] 
            Peripheral venous blood  and catheter tip were collected from all 150 
patients and rest of the samples like swab from the infected site, urine, 
sputum and stool were collected when clinically indicated. [Table4].   
Out of the 150 catheters subjected to direct grams stain demonstrated 
18.0% gram positive organisms with pus cells, (7.4%) showed gram  negative 
organisms with pus cells and (23.3%) of the catheters showed presence of 
polymorphs with no organisms. Catheters which showed organisms in direct 
gram stain also showed culture positivity in 80% cases. The remaining 20% of 
catheter was gram stain positive and culture negative but those patients had 
history of antibiotics prior to catheter removal. Peter et al.[98] reported 20%  
catheter tip gram staining  had pus cells with organisms  which was similar to 
our study.[Table 5]. 
Demonstration of catheter tip culture is usually performed by Maki’s  
semiquantitative  method which is a reference standard for more than 25 
years.[34] In our study we found that Maki’s technique was superior than other 
quantitative methods. 58.6% showed culture positivity by roll plate method. 
47.4% of the catheter culture positivity was detected by vortex method and 
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18.7% by segment washing method.[Table6] Our study was similar to the study of   
Emilio et al.[27]  who stated 98% of the catheter related infections were detected 
by roll plate method, therefore reported that roll plate method was best for 
detecting catheter related infections.[78,79,80]  
            The colony count of >102cfu/ml was detected  by quantitative culture 
of catheter tip and peripheral venous blood in 58.7% and 23.3% respectively 
(p Value <0.005) which is statistically significant. [Table7] Our study matches 
with study by Emilio et al.[27] that majority of catheter related infection were 
detected only by the roll plate method than quantitative culture. Our study 
correlates with the study of Siegman et al.[81]. Who showed that Maki’s 
technique was superior than other methods in detect ing catheter related 
infections. 
Our study the rate of occurrence   CRBSI  was noted  23.3% of cases and 
CRI in 35.5% of cases.[Table 8] Catheter related infection was the underlying cause 
for the development of  Catheter related blood stream infection in the course of  
hemodialysis and further complications like thromophlebitis, endocarditis and 
septic arthritis. Biofilm forming organisms like S.epidermidis and E.coli in 
catheters inturn may worsen the condition of the patient. The rate of occurance 
of CRBSI in our study was slightly higher than the study of  Pooja et al.[2] who 
reported 15% of CRBSI. However our study correlates with the study of Ratnaja 
et al., and Anil et al.,[Table 8] that they reported CRBSI in 12% of cases. 
Ramanathan et al. [56] reported CRBSI  in 40% of cases.. 
              In our study patients in the age group between 51-60 years showed 
more frequency of  CRBSI  (33.3%) followed by in those with the age group 
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of 18-20 years (27.4%.).[Table 9] Our study correlates with the study of Sexana 
et al.[23] that elderly patients are more prone to develop CRBSI. Pooja et al. 
reported 16% of CRBSI occurred between the age group of 15-30yrs, 20.5% 
in 31-45yrs and 9.1% in 46-60yrs[2] . Keiren et al. reported 40% incidence of 
CRBSI above 55 year of age.[91]  
Among the 150 catheters internal jugular vein was the commonly 
catheterized site. 20.8% of internal jugular venous catheters had CRBSI  
subclavian and femoral were inserted only in 3 patients each and showed  
66.6% and 100% culture positivity respectively.[Table10] Pooja et al[2], 
described 12% of culture positivity through internal jugular vein, 22.2% 
through subclavian vein. Merrer et al[71]. noted higher incidence of infection 
at the femoral venous site, compare to subclavian vein. Goetz et al.[72] also 
reported that the risk of infection with femoral venous site was more 
particularly if it was inserted as an emergency and as well as in post renal 
transplantation(72%).  Mermal et al[73], described that due to the close 
proximity to oropharygeal secretions, difficulty in monitoring the sterile 
dressing and internal jugular site, the risk of infection was more at IJV. 
According to Harsha et al.[26] the incidence of catheter infection was 33.3% in 
subclavian vein, 23.8% in femoral and 25% in IJV. Ratnaja et al.[4] reported 
that rate of catheter infection in femoral, IJV and subclavian was 7.6%, 5.6% 
and 0.7% respectively. Anil.K.Sexsana et al.[23]stated that infection through 
femoral vein was 7.6 episodes and internal jugular vein was 2.7 episodes per 
1000 catheter days. Our study correlates with the study of Harsha et al.[26]  
that more incidence of CRBSI was due to catheterization through subclavian 
vein. 
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European Renal Best Practice ERBP[52] recommends right IJV is the 
preferred site of catheterization followed by left IJV, the rate of stenosis in 
subclavian was more and the rate of infection was more in the femoral 
catheterization. Hence the use of femoral and subclavian catheterization was 
discouraged by ERBP. 
           In our study patients who underwent HD less than 5 times showed 
9.3% of developing CRBSI and those patients hemodialysis  between 5-10 
times showed 41.3%  and  more than 10 times showed 56%  of developing 
CRBSI. Patients in whom the catheter was placed in site more than 15 days  
had 51.4% CRBSI (p Value<0.005) which is statistically significant.  
Our study also found that CRBSI was increased as the number of 
dialysis increased.  This was similar to the study of Ramanathan et al.[56], 
Harsha et al.[26] who reported  that CRBSI  is significant among patients with 
catheter more than 3 days. Eyes et al.[74] found that patients with longer 
duration more than 7 days of catheterization were more prone to develop 
bacteremia.[Table 11-12]  
Among the risk factors analyzed, CRBSI was seen in 94.2% of patients 
with diabetes mellitus, 91.45% in anaemia, 88.5% in patients with history of 
previous dialysis and 2.8% cases with Hepatitis C infection. Our study correlates 
with the study of Powe et al.[95] who reported that anaemia, and diabetes  
mellitus was the predominant risk factors associated in patients with CRBSI. 
Hoen et al.[77] Robert et al.[85] also stated that 12-16% of patients with CRBSI 
had anaemia and diabetes mellitus.  Allon et al[86] Jonathan et at[96] and Rose et 
al [14] had reported that anaemia was the major underlying cause of patients with 
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CRBSI . Surendrakumar et al [82]Chandra et al [83] Reddy et al [84] reported  that 
Hepatitis C infection was prevalent in patients undergoing maintenance HD and 
the risk of developing CRBSI in 6 -7% of cases.[Table 13].  
Among the gram positive organisms isolated from catheter tip Methicillin 
resistant Staphylococcus aureus (MRSA) was the predominant organism in 
(27.7%) followed by Staphylococcus epidermidis (26.1%). Our study correlates 
with the study of Pooja et al[2] who stated that 67% of the CRBSI was due to 
gram positive cocci( 33%)contributed by Staphylococcus aureus and Coagulase 
negative Staphylococci.[2]. 
Among the gram negative bacteria causing CRI, the predominant 
isolate was  Acinetobacter baumannii (9%).  8% Pseudomonas aeruginosa, 
4.5% E.coli, 3.4% Klebsiella oxytoca, 2.2% Klebsiella pneumoniae followed 
by Proteus mirabilis and Proteus vulgaris 2.25% each.[Table 14]. The common 
bacteria isolated from catheter blood were MRSA(33.3%),  Pseudomonas 
aeruginosa(16.6%) and Acinetobacter baumannii( 50%). 
The predominant organism isolated  in urine with bacteriuria>10 5 
cfu/ml was E. coli (72.7%) followed by (27.2%) S.epidermidis. In patients 
with respiratory infection the bacteria isolated from sputum was Klebsiella 
pneumoniae(50%) and MSSA(50%). Among the 12 swabs cultured from 
infected site  MSSA and E.coli were isolated in each 25%. Of the 9 samples 
of catheter blood drawn for culture the same organism were isolated in 
corresponding peripheral blood culture also that MRSA(33.3%), Pseudomonas 
aeruginosa, Acinetobacter baumannii in 16.7% and 50% cases respectively. 
[Table 14] 
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Gram positive organisms were predominantly isolated in CRBSI 
namely  S.aureus MRSA (31.4%), MSSA(8.5%), S.epidermidis (8.5% )and 
S.schleiferi (5.7%). Among the gram negative isolated from catheter related 
blood stream infection (14.2%) due to Pseudomonas aeruginisa ,(11.4%) 
Acinetobacter baumannii followed by E.coli (8.5%),Klebsiella oxytoca(5.7%), 
Klebsiella pneumoniae (2.8%) and Proteus mirabilis (2.2%). Our study 
correlates with the study of Pooja et al., that  E.coli as the predominant gram 
negative bacteria[2]. Anil described that in  his study 12.8% of CRBSI is due 
to Acinetobacter baumannii,  E.coli (10.4%) Pseudomonas aeruginosa (2.3-
15.2%), Klebsiella pnemoniae(6.4%).[23]However Ratnaja et al in reported (2-
15%) Pseudomonas aeruginosa, (13%) Acinetobacter species  in his study. In 
contrast to his study CRBSI due to Gram negative bacteria was isolated lesser 
(15%) than gram positive cocci. [Table15] 
Ratnaja et al.[4] described (70.7%) of CRBSI was associated with gram 
positive organisms,(17.9%) by gram negative bacteria, (9.8%) with mixed 
gram positive and gram negative bacteria and  MRSA(6-29%). Lynn Johnson 
et al. showed that the predominant bacterial etiological agent of CRBSI was  
Staphylococcus aureus and Coagulase negative Staphylococci  [10].  Anil et 
al., also stated that 52-70% of CRBSI was due to gram positive cocci of that 
Staphylococcus aureus contributed (21.9-60%), Staphylococcus epidermidis  
(8.8-12%) and MRSA (6-8%) [23].Ramanathan et al, stated 26.7% of infection 
was due to MRSA [56]. Our study correlates with the study of Abdul Raguman 
et al. stated that  (77%) of the CRBSI was caused by gram positive bacteria.    
[76], Hoen et al reported (68%) of CRBSI was due to gram positive organisms. 
[77]  
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In the present study polymicrobial infection was found commonly in  
CKD patients. S.aureus and Candida albicans were the predominant isolates 
in the polymicrobial growth (11.4%) followed by Staphylococcus aureus and 
Klebsiella oxytoca. Our study was similar to the study of Ratnaja et al [4], and 
Anil et al who reported  that 16-20% polymicrobial growth was identified in 
patients with CRBSI. [Table 16] 
Among the 35 cases of CRBSI (11.4%) cases developed  hypotension 
and (5.7%) septic thrombophlebitis . The mortality rate was noted in (2.8%) 
of cases with CRBSI.[Table17]. 
A total of 12% fungal infections were noted in our study. Among the  
yeast  like fungi isolated from CRBSI (5.6%) Candida albicans, Candida 
parapsilosis and Candida tropicalis were isolated from both catheter and blood. 
(11.6%) Candida albicans and Aspergillus flavus, (5.6%) of Candida 
parapsilosis and Candida tropicalis, and Aspergillus  fumigatus  were isolated 
only from catheter .  Ratnaja et al reported 41% higher risk of CRBSI  and  
Abbot et al reported that 79% of Candida infection occurs in early hemodialysis 
especially in patients with diabetes mellitus and anaemia.[94] Our study is similar 
to the study of Ratnaja et al[4],  Hoen et al and Gandhi et al[13] in isolating fungal 
infections. Ramanathan et al reported (16% )of Candida albicans were isolated 
from central venous catheters in patients on HD.[56]  Bernad et al [89], Monina et 
al [90] reported in 1.7% of  Candida albicans  infections in central venous 
catheters.[Table 18]   (16.6%) Candida tropicalis, (22.2%) Candida albicans and 
(5.6%) of Candida parapsilosis were isolated from urine samples. 
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Parasitic infection was noted in 8.6%. The predominant parasite was 
Entamoeba histolytica  (41.6%), Giardia lamblia(30.7%), Cryptosporidium 
parvum(15.3%) of cases and Microsporidia(7.6%) cases. .[Table 19]  No malarial 
parasites were detected in the study group.  Parasitic infections were noted in 
patients  who were in an immunosuppressed state, diabetics and elderly age 
group. Seyrafian et al stated that 43.9%of HD patients infected with intestinal 
parasitic infection. Our study correlates with their study in detecting the 
parasitic infection in patients on HD.  Kulik et al [14] and  Seyrafian et al[75] 
stated the prevalence of Blastocystis spp(18%) was commonly noted in 
patients with renal impairment. Endolimax nana(14%), Cryptosporidium 
parvum(4-4.7%) and Entamoeba coli (4%) and (1.2%)Giardia were noted in 
patients with high uremic state. He stated that high uremic state and altered 
immune mechanism, neutropenia in HD patients promotes the parasitic 
infection and worsen the state of aneamia and aggravates the state of 
immunosuppression. Our study correlates with the study of  Seyrafian et al in 
demonstrating the parasites in patients with renal impairment.  
Anti microbial susceptibility testing was done as per CLSI guidelines. 
Among the Gram positive isolates Staphylococcus aureus and Coagulase 
negative Staphylococci showed 100% sensitivity to Amikacin and 
Amoxycillin clavulinic acid. A total of 37 isolates of Methicillin resistant 
Staphylococcus aureus all were sensitive to Vancomycin within the sensitive 
range of MIC. [Table 20,23] 
 Among the Enterobacteriaceae isolates screened  for  ESBL 
production 33.3% Proteus mirabilis, 37.5% of Escherichia coli, 20% of 
Klebsiella pneumoniae, 50% of Proteus vulgaris and 14.2% of Klebsiella 
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oxytoca were confirmed by Double disc synergy test.  All these isolates 
showed 100% sensitivity to Imipenem and Cefoperazone sulbactum.   
Among gram negative non fermenters Pseudomonas aeruginosa, and 
Acinetobacter baumannii showed 100% sensitivity to Imipenem and 
Cefoperazone sulbactum. Among gram negative bacilli, production of 
extended spectrum lactamaces was the mechanism of resistance in them. 
None of the isolates were found to be MBL producers and Amp C producers. 
In our study majority of the gram positive and gram negative organisms 
showed 100%  sensitive to Amikacin.[Table 21,22 24]  
Antifungal susceptibility testing was done by microdilution method as 
per the CLSI guidelines.  Aspergillus flavus and Aspergillus fumigatus were 
sensitive to Amphotericin B, Voriconazole, Itraconazole within the MIC 
range. All the Candida isolates were sensitive to Fluconazole, Amphotericin 
B within the susceptibility range. None of the organisms isolated in our study 
had  multi drug resistance.[Table 25,26]  
  
95 
 
SUMMARY 
This study was conducted in the Institute of Microbiology, in association 
with Department of Nephrology, Madras Medical College and Rajiv Gandhi 
Government General Hospital, Chennai from September 2011 to October 2012.  
 A total number of 150 cases were included in the study after satisfying 
the inclusion and exclusion criteria.  
  Out of the 150 patients, 78 males (52%) and 72 females (48%) were 
included in the study with the male predominance. Majority of the 
patients (67.4%) in the study group belonged to the age group of 21 -30 
years.  
 Chronic kidney disease (70.7%) was the predominant Nephrological 
lesion for which hemodialysis was indicated.  
 Diabetes mellitus (35%) was the most common underlying cause for 
hemodialysis among the chronic kidney disease, acute diarrheal disease 
(50%) was the predominant cause for HD among acute kidney injury 
patient.   
 58.3% and 23.3% of aerobic bacteria was isolated from catheter tip and 
blood respectively. 4.6%  and 2% of   fungi were isolated from catheter 
tip and blood respectively 
 Gram stain demonstrated gram positive organism in 18% of cases.  
Gram negative organisms in 7.4% cases 
 Among the 150 catheters processed 58.7% culture positivity was 
observed by roll plate method and 47.4%, 18.7% by vortex and 
segment washing method respectively.  
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 Colony count of >102 was noted in 58.7% of catheter and 23.3% 
peripheral blood by quantitative culture.  
 35.3% cases had catheter related infection without positive blood 
culture and categorized as catheter related infection(CRI). 23.3% cases 
with positive blood culture along with catheter  were categorized as 
catheter related blood stream infection(CRBSI).  
 CRBSI was noted commonly in the age group of 51-60 years (33.3%). 
 Maximum number of catheters were inserted through internal jugular 
vein and CRBSI was noted in 20.8% of IJV catheters. But femoral 
catheterization had a higher risk of developing blood stream infection. 
 Patients who have undergone hemodialysis more than 10 times showed 
maximum risk of developing CRBSI.  
 51.4% of catheter related blood stream infection was observed in 
patients with catheter in place for more than 15 days followed by 
34.3% between 11-15 days.   
 Diabetes mellitus was the commonest risk factor found in patient with 
CRBSI 94.2% followed by anaemia.  
 31.4% of MRSA was isolated from peripheral venous blood and 27.2% 
from catheter tip. Among the gram negative organism Pseudomonas 
aeruginosa was the predominantly isolated in catheter tip and 
peripheral venous blood 7%, 14.2% respectively  
 Gram positive organisms (31.4%) MRSA was the predominant isolate 
in CRBSI. Pseudomonas aeruginosa  (14.2%) was the predominant 
gram negative organism isolated in CRBSI.  
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 A total of 6 cases had poly microbial growth.  Staphylococcus aureus 
and Candida species were isolated in 11.4%  CRBSI 
 Among the 35 cases of CRBSI 11.4% developed hypotension and 5.7% 
septic thrombophlebitis and mortality was noted in 2.8% cases.  
 Out of the 18(12%) isolates of fungi C.albicans, C.tropicalis, 
C.parapsilosis constituted 5.6%. 
 Entamoeba histolytica was predominantly seen in 46.1% 
 Staphylococcus aureus, Staphylococcus epidermidis , Staphylococcus 
schleiferi and Staphylococcus warneri showed 100% sensitive to 
Amikacin. 22.7%, 13.1%, 33.3% of MRSA were detected in catheter 
tip, peripheral venous blood and catheter blood respectively.  
 Majority of the gram negative organisms were sensitive to Amikacin  
 All the enterobacteriaceae isolates were sensitive to Cefoperazone and 
sulbactuam.  
 33.3% of Proteus mirabilis, 37.5% of E.coli, 16.6% Klebsiella 
pneumoniae, 50% of Proteus vulgaris and 14.2% Klebsiella oxytoca 
were ESBL producers.  
 All the Methicillin Resistant Staphylococcus aureus were sensitive to 
vancomycin.  
 All the Candida isolates were 100% sensitive to Fluconazole and 
Amphotericin B.  
 Aspergillus flavus and Aspergillus fumigatus showed 100% sensitive to 
Amphotericin B, Itraconazole, Voriconazole.  
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CONCLUSION 
This study was conducted in the Institute of Microbiology, in association 
with Department of Nephrology, Madras Medical College and Rajiv Gandhi 
Government General Hospital, Chennai from September 2011 to October 2012.  
Majority of the patients (67.4%) in the study group belonged to the age group of 
21-30 years.  
Catheter related infection was found in 53 (35.3%) of cases. 
Catheter related blood stream infection was found in 35 cases (23.3%) 
Fungal infection was seen in12% of patients who underwent hemodialysis. 
Gram stain method provides rapid identification of infection in catheter.  
Site, duration and number of catheterization play a major role in CRBSI and 
complications. 
Negative Bacterial culture was seen in 62 cases (41.4%)  
Parasitic infection was noted in 8.6% of patients who underwent hemodialysis 
Gram stain method is complementary to roll plate method and indicates rapid 
identification of infection in catheter.  
Semi quantitative roll plate method is superior to vortex and segment washing 
methods. 
Quantitative culture of catheter tip and peripheral venous blood appears to be good 
approach in detecting catheter related blood stream infection.  
Vortex and Endoluminal technique takes a longer time and requires technical 
expertisation. 
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Predominant organism causing blood stream infection was Staphylococcus aureus 
31.4%, followed by S. epidermidis, 8.5% 
All the MRSA were sensitive to vancomycin with the MIC less than 2μg/ml  
Among the Gram negative bacteria Pseudomonas aeruginosa-14.2% and 
Acinetobacter baumannii-11.4% were the causatives for CRBSI. 
50% of Proteus vulgaris, 33.3% of P. mirabilis and 37.5% of Escherichia coli were 
Betalactamase producers. 
All gram positive and gram negative bacteria were sensitive to Amikacin. 
Hypotension was the most common complication in patients with CRBSI. 
Apart from diabetes mellitus and anaemia, history of infection in the previous 
dialysis and the number of dialysis were the common predisposing factors for 
CRBSI. 
Following identification of Acinetobacter baumannii in catheter blood for three 
patients the catheters were removed and patients recovered and treated effectively.  
None of the organism isolated in this study had multi drug resistance.  
PREVENTION  
Risk of Catheter Related Blood Stream Infection can be greatly reduced by strict 
aseptic technique.  
Strict hand washing should be practiced.  
Changing of catheters with sterile precaution is mandatory.  
Health education regarding taking care of catheter should be done. 
Appropriate antibiotic therapy to prevent drug resistance is one of the important 
therapeutic approach in prevention of CRBSI. 
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ABBREVIATIONS  
AKI - Acute Kidney Injury 
ARF - Acute Renal Failure 
ATCC - American Type Culture Collection 
AVF - Arterio Venous Fistula 
BSI - Blood Stream Infection 
CDC - Centers for Disease Control 
CKD - Chronic Kidney Disease 
CLSI - Clinical and Laboratory Standards Institute  
CRBSI - Catheter Related Blood Stream Infection 
CRI - Catheter Related Infection 
CVC - Central Venous Catheter   
ERBP - European Renal Best Practice  
HD - Hemodialysis  
HIPAC - Healthcare Infection control Practices Advisory 
Committee  
IDSA - Infectious Disease Society of America 
IJV - Internal Jugular Vein 
IVC                         -         Intravascular catheter 
MHC - Major Histo Compatibility Complex  
RRT - Renal Replacement Therapy 
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PROFORMA 
Name : IP No : 
Age : Ward : 
Sex : 
Occupation : 
Address : 
Date of Admission: 
Presenting Complaints:  
1. Fever  2.Chills 3. Head ache  4. Vomiting  
5. Abdominal Pain   6. Diarrhea  
Local Examination 
1. Warmth  2. Redness 3.Swelling 4. Discharge 
Risk Factors/ Demographic Profile of the patients:  
Prior location before admission 
Hypertension 
Prior antibiotic therapy 
Known retroviral disease 
H/o.Blood transfusion 
Hepatitis B 
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Hepatitis C 
Steroid Therapy 
Diabetes  
H/o. Prior dialysis 
H/o. Renal transplant or Renal biopsy 
H/o. Infection during previous heemodialysis or hospitalization 
Nature of renal disease 
Duration of dialysis & catheterization 
Laboratory evaluation:  
Complete haemogram 
Platelet Count 
ESR 
Blood Sugar: Fasting & Post Prandial 
Urea 
Creatinine  
Urine Routine 
USG Abdomen 
MICROBIOLOGICAL INVESTIGATION 
a. Microscopic examination 
Gram Stain 
Giemsa Stain  
Wet Mount 
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Lactophenol cotton blue mount 
Iodine mount 
Potassium Hydroxide mount 
Modified acid fast staining 
b. Culture 
Bacterial Culture 
Fungal Culture 
c. Antimicrobial susceptibility pattern 
d. Antimicrobial susceptibility pattern 
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APPENDIX 
A. STAINS AND REAGENTS 
I. Gram staining 
Methyl violet (2%)  l0g Methyl violet in 100ml 
absolute alcohol in 1litre of 
distilled water (primary stain)  
Grams Iodine  l0g Iodine in 20g KI (fixative) 
Acetone  Decolourising agent 
Carbol fuchsin 1%  Secondary stain 
II. Lactophenol cotton blue stain 
Lactic acid  20 ml 
Phenol  20ml 
Cotton blue (dye)  0.5g 
Glycerol  40ml 
Distilled water  20ml. 
III. 10% KOH 
Potassium hydroxide  l0g 
Glycerol l0ml 
Distilled water  80ml 
LUGOLS IODINE   
Pottasium Iodide 10 gm 
Iodine 5 gm 
Distilled Water 100 ml 
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B. MEDIA USED 
1. Mac Conkey agar 
Peptone  20g 
Sodium taurocholate  5g 
Distilled Water  1 ltr 
Agar  20g 
2% neutral red in 50% ethanol  3.5ml 
10% lactose solution  100mI 
Dissolve peptone and taurocholate in water by heating. Add agar and 
dissolve it in steamer. Adjust pH to 7.5. Add lactose and neutral red shake 
well and mix. Heat in free steam (100°C) for 1 hour, then autoclave at 115°C 
for 15 minutes. 
2. Blood agar (5% sheep blood agar) 
Peptone  l0g 
NaCl  5g 
Distilled water  1 Ltr 
Agar  10g 
Dissolve ingredients in distilled water by boiling, and add 5% sheep 
blood(sterile) at 55°C adjust pH to 7.4.  
3. Chocolate agar 
Sterile defibrinated blood  10 ml 
Nutrient Agar (melted)  100 ml 
When the temperature was about 75°C, sterile blood was added with 
constant agitation. After addition of blood, kept in water bath and heating was 
continued till the blood changed to chocolate colour. Cooled to about 50° C 
and poured about 15ml into petri dishes with sterile precaution. 
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4. Sabouraud’s dextrose agar 
Dextrose  40g 
Peptone  l0g 
Agar  20g 
Distilled water  l000ml 
pH = 5.5 
5. Mueller- Hinton Agar 
Beef infusion  300ml 
Caesein hydrolysate  17.5g 
Starch  1.5g 
Agar  10g 
Distilled water  1 ltr 
pH = 7.4 
Sterilise by autoclaving at 121ºC for 20 mins 
C. MEDIA REQUIRED FOR BIOCHEMICAL 
IDENTIFICATION 
1.Oxidase Reagent 
Tetra methyl p-phenylene diamine dihyrochloride- 1% aqueous   
solution. 
2.Catalase 
3% hydrogen peroxide 
3.Indole test 
Kovac’s reagent 
Amyl or isoamyl alcohol  150ml 
Para dimethyl amino benzaldehyde  10g 
Concentrated hydrochloric acid  50ml 
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96Dissolve the aldehyde in the alcohol and slowly add the acid. 
Prepare in small quantities and store in the refrigerator. Shake gently before 
use. 
4.Christensen’s Urease test medium 
Peptone  1g 
Sodium chloride  5g 
Dipotassium hydrogen phosphate  2g 
Phenol red  6ml 
Agar  20g 
Distilled water  1 ltr 
10% sterile solution of glucose  l0ml 
Sterile 20% urea solution  100ml 
Sterilize the glucose and urea solutions by filtration. Prepare the  basal 
medium without glucose and urea, adjust to pH 6.8-6.9 and sterilize by 
autoclaving in a flask at 121°C for 30min. Cool to about 50°C, add the 
glucose & urea, and tube the medium as slopes.  
5. Simmon’s Citrate Medium 
Koser’s medium  1 ltr 
Agar  20g 
Bromothymol blue 0.2%  40ml 
Dispense, autoclave at 121°C for 15 min and allow to set as slopes  
6. Triple Sugar Iron medium 
Beef extract  3g 
Yeast extract  3g 
Peptone  20g 
Glucose  1g 
Lactose  l0g 
Sucrose  l0g 
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Ferric citrate  0.3g 
Sodium chloride  5g 
Sodum thiosulphate  0.3g 
Agar  12g 
Phenol red 0.2% solution  12ml 
Distilled water  1 ltr 
Heat to dissolve the solids, add the indicator solution, mix and tube. 
Sterilize at 121°C for 15 min and cool to form slopes with deep butts.  
7. Glucose phosphate broth 
Peptone  5g 
Dipotassium hydrogen phosphate 5g 
Water  1 ltr 
Glucose 10% solution  50ml 
Dissolve the peptone and phosphate and adjust the pH to 7.6. Filter 
dispense in 5ml amounts and sterilize at 121°C for 15min. Sterilize the 
glucose solution by filtration and add 0.25ml to each tube. 
Methyl Red Reagent 
Methyl Red  10mg 
Ethyl alcohol  30ml 
Distilled water  20ml 
Voges Proskauer Reagent 
Reagent A: Alpha naphthol  5g 
Ethyl alcohol  100ml 
Reagent B: Potassium hydroxide  40g 
Distilled water  100ml 
8. Peptone water fermentation test medium. 
To the basal medium of peptone water, add sterilised sugars of 1% indicator 
bromothymol blue with Durham’s tube.  
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Basal medium peptone water 
Sugar solutions: 
Sugar  1ml 
Dislilled water  100ml 
pH = 7.6. 
9. Mannitol motility medium 
Agar  5g 
Peptone  1g 
Potassium nitrate  1g 
Mannitol  2g 
Phenol red indicator 
Distilled water  1000ml 
pH 7.2 
10. Phenolphthalein diphosphate agar 
Sterilize a 1% aqueous solution of sodium phenolphthalein diphosphate by 
filtration and store at 4ºC 
Add 10ml of this solution to 1000ml melted nutrient agar cooled to 50ºC 
and pour plates 
Grow the staphylococcus overnight at 37ºC on the medium 
Invert the plate and pour a few drops of ammonia solution SG 0.88 into 
the lid 
Read as positive a culture whose colonies turn bright pink within a few 
minutes. The colour soon fades. 
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11. Potassium nitrate broth 
Potassium nitrate (KN03)  0.2gm 
Peptone  5.0gm 
Distilled water  100ml 
The above ingredients were mixed and transferred into tubes in 5 ml 
amount and autoclaved. 
12. Phenyl alanine deaminase test 
Yeast Extract  3g 
Dl-Phenylalamine  2 g 
Disodium hydrogen phosphate  l g 
Sodium Chloride  5 g 
Agar  12g 
Distilled water  1 lr 
pH 7.4 
Distributed in tubes and sterilized by autoclaving at 121° C for 1 5 
minutes, allowed to solidify as long slopes. 
13. Sugar fermentation medium 
Peptone  15g 
Andrade’s indicator  10 ml 
Sugar to be tested  20g 
Water  1litre 
Andrade’s indicator is prepared from 0.5% aqueous acid fuchsin to 
which sufficient 1M sodium hydroxide has been added to turn the colour of 
the solution yellow. 
Dissolve the peptone and Andrade’s indicator in 1litre of water and add 
20g of the sugar; sugars to be tested generally include glucose, sucrose, 
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lactose and maltose. Distribute 3ml amounts in standard test tubes containing 
an inverted Durham tube. Sterilize by steaming at 100 degree C for 30 min on 
3 consecutive days. 
14. Trypticase soy broth  
Pancreatic digest of casein  17 gm,  
Peptic digest of soyabean meal  3 gm 
Sodium Chloride 5 
Dipottasium hydrogen phosphate 2.5 
Dextros  2.5 
pH 7.3 + 2 
30 gm in 1000 ml of distilled water  
15. Xylose lysine desoxycholate (XLD) agar 
Yeast extracts 3 gm 
Xylose 3.75 g 
Lactose 7.5 gm 
Sucrose 7.5 gm 
L.Lysine HCL 5 gm 
Sodium Chloride 5 gm 
Sodium Deoxycholate 2.5 gm 
Sodium Thiosulphate 6.8 gm 
Ferric Ammonium Citrate 8 gm 
Phenol red indicator 
Agar 15 gm 
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16. Deoxcholate citrate agar – DCA 
Meat Extract 20 mg 
Peptone 20 gm 
Neurtral ned 2% 
in 50 ml ethanol 5 ml 
Lactose 40 gm 
Water 4 lt 
pH 7.4 
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MASTER CHART KEY  
M - Male 
F - Female 
Y - Yes 
N - No 
HOS - History of Steroids  
DOC - Duration of Catheterization  
HT - Hypertension 
PRT-HD - Post Renal Transplant-HD 
BA - Bronchial Asthma   
NSAID - Non Steroidal Anti Inflammatory Drug 
BT - Blood Transfusion 
DOH   - Duration of Hospitalization   
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